Companies news

CHS Inc., (Nasdaq: CHSCP) a leading energy, grains and foods company today announced it has invested in a project that will result in partial ownership of a grain export terminal with GN Terminals, Odessa. The two companies will operate an export terminal there with expected annual grains shipping capacity of two million tons.

Under the agreement and upon closing, CHS (www.chsinc.com) will manage part of the terminal's capacity, allowing it to manage its own rail cars, trucks and ships through the Odessa terminal. CHS operations in Odessa will be managed from the CHS Europe office in Geneva, Switzerland, and all grain will be marketed as CHS.

"Our Black Sea investments support the company's strategy of being a major supplier of grain to the global marketplace from both domestic and key international sources," says Claudio Scarrozza, general manager, CHS Europe.

CHS Inc. is a diversified energy, grains and foods company committed to providing the essential resources that enrich lives around the world. A Fortune 200 company, CHS is owned by farmers, ranchers and cooperatives, along with thousands of preferred stockholders across the United States. CHS supplies energy, crop nutrients, grain, livestock feed, food and food ingredients, along with business solutions including insurance, financial and risk management services. The company operates petroleum refineries/pipelines and manufactures, markets and distributes Cenex(R) brand refined fuels, lubricants, propane and renewable energy products. CHS is listed on the NASDAQ at CHSCP.

This document contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 that are based on management's current expectations and assumptions. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the potential results discussed in the forward-looking statements. The company undertakes no obligations to publicly revise any forward-looking statements to reflect future events or circumstances. For a discussion of additional factors that may materially affect management's estimates and predictions, please view the CHS Inc. annual report filed on Form 10-K for the year ended Aug. 31, 2008, which can be found on the Securities and Exchange Commission web site (www.sec.gov) or on the CHS web site www.chsinc.com.

CHS Inc.

Lani Jordan, +1-651-355-4946, lani.jordan@chsinc.com, or Annette Degnan, +1-651-355-5126, Annette.degnan@chsinc.com, both of CHS Inc.

Salesforce.com Executive Vice President, Marketing and Alliances, to Present at RBC Virtual Investor Bus TourEvent to be Webcast Live on salesforce.com's Investor Relations Website

SAN FRANCISCO, Sept. 2 /PRNewswire-FirstCall/ -- Salesforce.com , the enterprise cloud computing company today announced that George Hu, Executive Vice President, Marketing and Alliances, at salesforce.com, will present at the RBC Virtual Investor Bus Tour on Tuesday, September 8, 2009 at 9:00 am (PT) / 12:00pm (ET) in San Francisco, CA.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050216/SFW105LOGO)

An audio webcast of Mr. Hu's presentation will be available on salesforce.com's website at http://www.salesforce.com/investor.

About salesforce.com

Salesforce.com is the enterprise cloud computing company. The company's portfolio of Salesforce CRM applications, available at http://www.salesforce.com/crm/, has revolutionized the ways that companies collaborate and communicate with their customers across sales, marketing and service. The company's Force.com platform (http://www.salesforce.com/platform/) enables customers, partners and developers to quickly build powerful business applications to run every part of the enterprise in the cloud. Based on salesforce.com's (http://salesforce.com/) real-time, multi-tenant architecture, Salesforce CRM and Force.com offer the fastest path to customer success with cloud computing.

As of July 31, 2009, salesforce.com manages customer information for approximately 63,200 customers including Allianz Commercial, Dell, Dow Jones Newswires, Japan Post, Kaiser Permanente, KONE, and SunTrust Banks. Any unreleased services or features referenced in this or other press releases or public statements are not currently available and may not be delivered on time or at all. Customers who purchase salesforce.com applications should make their purchase decisions based upon features that are currently available. Salesforce.com has headquarters in San Francisco, with offices in Europe and Asia, and trades on the New York Stock Exchange under the ticker symbol "CRM". For more information please visit http://www.salesforce.com/, or call 1-800-NO-SOFTWARE.

Copyright (c) 2009 salesforce.com, inc. All rights reserved. Salesforce and the "no software" logo are registered trademarks of salesforce.com, inc., and salesforce.com owns other registered and unregistered trademarks. Other names used herein may be trademarks of their respective owners.

Photo: http://www.newscom.com/cgi-bin/prnh/20050216/SFW105LOGO
http://photoarchive.ap.org/
PRN Photo Desk photodesk@prnewswire.com salesforce.com

CONTACT: David Havlek, Investor Relations, +1-415-536-2171,
dhavlek@salesforce.com, or Gordon Evans, Public Relations, +1-415-536-7608,
gevans@salesforce.com, both of salesforce.com

Web Site: http://www.salesforce.com/

Martek Announces Third Quarter 2009 Financial Results- Record non-infant formula nutritional sales of $10.6 million, increase of 41% over third quarter of 2008 - Record quarterly gross margin of 43.7% - Third quarter total revenues and earnings in line with previously disclosed guidance - Fourth quarter 2009 revenue guidance of $87 million to $92 million - Full fiscal year 2009 earnings guidance of $1.20 to $1.24 per share, projected pre-tax earnings growth of 10% to 15% over fiscal 2008

COLUMBIA, Md., Sept. 2 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation today announced its financial results for the third quarter of fiscal 2009. Revenues for the third quarter were $77.8 million, down 12% from $88.4 million in the third quarter of fiscal 2008. Net income was $8.9 million, or $0.27 per diluted share, for the third quarter of fiscal 2009, a 4% decrease compared with $9.3 million, or $0.28 per diluted share, in last year's third quarter.

Commenting on the quarter, Chief Executive Officer Steve Dubin said, "Martek's third quarter 2009 financial results benefited from a 41% quarter over quarter increase in non-infant formula product sales, a 220 basis point gross margin improvement from last year, and our cost control efforts, but, as anticipated and disclosed at the time of our second quarter earnings press release, we were negatively impacted by de-stocking of inventory by certain of our infant formula customers. Despite some continuing effects of this customer de-stocking, I expect a strong fourth quarter for both revenues and earnings. Looking forward to 2010, the de-stocking issue should be behind us and our growing non-infant formula business coupled with an expected resumption in growth in our infant formula business should lay a solid foundation for 2010."

Revenue Summary

Product sales in the third quarter of fiscal 2009 decreased to $75.0 million from $83.5 million in the third quarter of fiscal 2008. The revenue decline in the current year's third quarter was caused by the previously announced de-stocking of inventory by certain infant formula customers. The effect of the de-stocking was partially offset by record non-infant formula nutritional revenues of $10.6 million in the third quarter of fiscal 2009. The 41% increase in non-infant formula nutritional products compared to the prior year's third quarter was led by significantly higher sales to the pregnancy and nursing market.

A breakdown of product sales by market for the third quarter and year-to-date periods (in thousands) follows:

Three months ended Nine months ended July 31, July 31, --------------------- ----------------------- % % incr incr 2009 2008 (decr) 2009 2008 (decr) ------------------------------------------------------------------------ Infant formula market $63,320 $74,815 (15%) $215,294 $223,483 (4%) Food and beverage market 2,681 2,526 6% 8,278 7,793 6% Pregnancy and nursing, nutritional supplements and animal feeds 7,931 5,019 58% 20,396 15,424 32% Non-nutritional products 1,112 1,121 (1%) 3,250 3,265 (1%) ----- ----- ----- ----- Total product sales $75,044 $83,481 (10%) $247,218 $249,965 (1%) ======= ======= ======== ========

In addition, contract manufacturing sales in the third quarter totaled $2.8 million, compared with $4.9 million a year ago due to a planned reduction in the scope of the Company's contract manufacturing activities over the long-term. While the Company expects to continue reducing the scope of its contract manufacturing activities, Martek will provide contract services to both existing and new customers if reasonable profit margins can be generated, there is no impact to the Company's higher margin nutritional oils business or the Company believes that such services could have a strategic fit.

Gross Margin and Operating Expenses

Overall gross margin for the third quarter of fiscal 2009 was 43.7%, a record gross margin, and a significant increase over the 41.5% gross margin realized in the third quarter of fiscal 2008. The improvement resulted largely from ARA cost reductions and DHA productivity increases.

Research and development expenses in the third quarter of fiscal 2009 were $6.6 million, an increase of 5% over the corresponding quarter of last year. The increase relates primarily to development work focusing on offerings for new markets and broadening the array of foods and beverages in which the Company's life'sDHA(TM) can be incorporated. The Company continues to expect quarter-to-quarter fluctuations in research and development expenses mainly due to the timing of outside services, including third-party clinical trial services.

During the third quarter of fiscal 2009, selling, general and administrative expenses ("SG&A") were $11.4 million, a decrease from $13.6 million in last year's third quarter. The Company continues to closely manage its SG&A spending levels. Martek expects that for fiscal 2009, SG&A will be lower than fiscal 2008 levels on both a percentage of revenue and absolute dollar basis reflecting the cost management measures employed by the Company to address economic challenges. Such cost management measures during the third quarter included reductions to estimated annual incentive compensation payouts which resulted in a reversal of certain previously accrued incentive compensation expenses.

Financial Position

As of the end of the third quarter, Martek had $129.3 million in cash and cash equivalents, a minimal amount of debt and the entire balance of its long-term revolving credit facility ($135 million) available for future borrowing. For the nine months ended July 31, 2009, the Company generated $40.0 million of cash from operating activities, with the third quarter providing $14.4 million of this total. Year-to-date operating cash flows were impacted by an increase in ARA inventory levels. Consistent with prior years, the timing of Martek's purchases of ARA are largely dependent upon DSM's scheduled production runs. Significant ARA production runs by DSM during the third quarter coupled with lower sales served to increase ARA inventory by approximately $15 million compared to the second quarter. In general, Martek purchases a minimal amount of ARA from DSM during the fourth quarter. As a result, the Company's total inventory value at October 31, 2009 is projected to be between $115 million and S118 million.

Significant Recent Events -- Joint Development Agreement with BP - Martek entered into a Joint Development Agreement (JDA) with BP to work on the production of microbial oils for biofuels applications. Under the terms of the multi-year agreement, Martek and BP will work together to establish proof of concept for large-scale, cost effective microbial biodiesel production through fermentation. BP has agreed to contribute up to $10 million to this initial phase of the collaboration with Martek performing the biotechnology research and development associated with these initial development activities. All intellectual property developed under the JDA will be owned by BP, with an exclusive license to Martek for application and commercialization in nutrition, cosmetic and pharmaceutical applications. Additionally, each party is entitled to certain payments from technology that is commercialized in the other party's field. -- Multi-Year Sole-Source Infant Formula Supply Agreements - Martek entered into a multi-year sole-source supply agreement with Puleva Food for the use of ARA in infant formulas produced by Puleva and sold in Spain. Puleva is part of the Ebro-Puleva group, Spain's largest agro-food business. Martek also entered into a multi-year sole-source supply agreement with Milk Powder Solutions under which Martek will serve as Milk Powder Solutions' exclusive supplier for all of its ARA needs for infant formula products in China and Vietnam under the Gold Cow brand name. -- Non-Infant Formula Product Launches - Several non-infant formula nutritional products with Martek's life'sDHA(TM) were launched by Martek's customers, including Parent's Choice(TM) Pediatric Drink, Walgreens Finest Natural Multi-vitamins and Walgreens Flax + DHA dietary supplement. -- Approval in European Union of New Food Applications for life'sDHA(TM) - Martek received approval from the Standing Committee On The Food Chain and Animal Health (SCFCAH) of the European Union for the use of Martek's life'sDHA(TM) in bakery products, cereal bars, and beverages, including milk-based and milk analogue drinks, throughout the 27 Member States of the European Union. This expands the current categories approved in 2003 which include breakfast cereals, spreadable fat and dressings, certain dairy products and food supplements. -- New Scientific Data Published on DHA - The benefits of DHA supplementation were recently discussed in the following publications. -- A report published in Developmental Neuropsychology (June 2009) evaluated resting heart rate during the first six months of life in healthy, full-term infants. The newborns were either breastfed or given cow's milk-based or soy-based commercial infant formula containing different levels of DHA and ARA throughout the study period. Results showed that infants fed higher levels of DHA and ARA from either breast milk or infant formula had lower heart rates and higher values for heart rate variability measures compared to infants fed lower levels of DHA and ARA. According to the authors, these results indicate that adequate DHA is important for parasympathetic tone during this important period in development of cardiovascular regulation. -- A study published in the British Journal of Ophthalmology (March/April 2009) reported findings from a multi-year study of the effects of diet on the progression of age-related macular degeneration. This large clinical trial supplemented over 2,000 people with 5, 6, and 18 times the Recommended Dietary Allowance levels of vitamins C, E and/or zinc and other minerals. In this current report, the investigators quantified the dietary intake of DHA and EPA in the study groups as well. Results showed that consuming a diet rich in DHA slowed the progression of early age-related macular degeneration and that the DHA benefit occurred independently from EPA and the usual study supplements. Financial Guidance

Martek expects total revenues for the fourth quarter of fiscal 2009 to be between $87 million and $92 million with fourth quarter infant formula revenue projected to be between $69 million and $75 million and fourth quarter non-infant formula nutritional revenue projected to be between $9.5 million and $11.5 million. Contract manufacturing and services revenue is projected to be between $6.0 million and $6.5 million in the fourth quarter. The expected revenue increase from prior periods in the contract area is attributable to the additional production by Martek of the starting material used to produce an anti-viral drug for the treatment of influenza and the BP arrangement noted above. Fourth quarter gross margin is expected to be between 43% and 44%. Net income for the fourth quarter is projected to be between $10.4 million and $11.8 million, and diluted earnings per share are projected to be between $0.31 and $0.35.

For the full fiscal year 2009, Martek expects total revenues to be between $345 million and $350 million. Net income for the full fiscal year 2009 is projected to be between $40.0 million and $41.4 million, and diluted earnings per share are projected to be between $1.20 and $1.24, a pre-tax earnings increase of between 10% and 15% over fiscal 2008.

Investor Conference Call Webcast

Martek will host a conference call and Webcast for investors to review its third quarter results and fiscal 2009 outlook at 4:45 p.m. Eastern Time on Wednesday, September 2, 2009. Access to the live audio Webcast is available through Martek's website at http://investors.martek.com/. The webcast will be available for replay through the close of business on October 2, 2009.

General

Sections of this release contain forward-looking statements concerning, among other things: (1) Martek's expectations regarding future revenue growth in and customer demand from the infant formula, pregnancy and nursing, nutritional supplements, animal feeds and food and beverage markets; (2) its expectations regarding revenue, gross margin, operating expenses and income for the fourth quarter of and full fiscal year 2009; (3) its expectations and beliefs regarding the impact of customer de-stocking on revenues in the fourth quarter of fiscal 2009; and (4) its expectations regarding launches by customers of products containing Martek's life'sDHA(TM) and Martek's contract manufacturing business. Furthermore, Martek's operating results are subject to quarter-to-quarter fluctuations, some of which may be significant. The forward-looking statements noted above are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors and cautionary statements set forth herein and in the Company's filings with the Securities and Exchange Commission, including, but not limited to, Part I, Item 1A of the Company's Form 10-K for the fiscal year ended October 31, 2008 and other filed reports on Form 10-K, Form 10-Q and Form 8-K.

About Martek

Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/.

CONTACT Kyle Stults Investor Relations (410) 740-0081 kstults@martek.com MARTEK BIOSCIENCES CORPORATION Summary Consolidated Financial Information (Unaudited - $ in thousands, except per share data) Unaudited Condensed Consolidated Statements of Income Data Three months ended Nine months ended July 31, July 31, 2009 2008 2009 2008 Revenues: Product sales $75,044 $83,481 $247,218 $249,965 Contract manufacturing sales 2,790 4,922 10,390 12,045 ----- ----- ------ ------ Total revenues 77,834 88,403 257,608 262,010 ------ ------ ------- ------- Cost of revenues: Cost of product sales 41,129 47,334 137,337 143,010 Cost of contract manufacturing sales 2,675 4,374 10,101 10,826 ----- ----- ------ ------ Total cost of revenues 43,804 51,708 147,438 153,836 ------ ------ ------- ------- Gross margin 34,030 36,695 110,170 108,174 ------ ------ ------- ------- Operating expenses: Research and development 6,604 6,278 20,510 19,078 Selling, general and administrative 11,439 13,554 37,411 40,769 Amortization of intangible assets 1,534 1,919 4,910 5,475 Other operating expenses 234 341 956 590 --- --- --- --- Total operating expenses 19,811 22,092 63,787 65,912 ------ ------ ------ ------ Income from operations 14,219 14,603 46,383 42,262 Interest income (expense) and other, net 81 337 427 863 -- --- --- --- Income before income tax provision 14,300 14,940 46,810 43,125 Income tax provision 5,372 5,608 17,259 15,922 ----- ----- ------ ------ Net income $8,928 $9,332 $29,551 $27,203 ====== ===== ======= ======= Basic earnings per share $0.27 $0.28 $0.89 $0.83 ==== ==== ===== ===== Diluted earnings per share $0.27 $0.28 $0.89 $0.82 ==== ==== ===== ===== Shares used in computing basic earnings per share 33,234 33,016 33,191 32,892 Shares used in computing diluted earnings per share 33,346 33,408 33,346 33,235 Unaudited Condensed Consolidated Balance Sheets Data July 31, October 31, 2009 2008 ---- ---- Assets: Cash and cash equivalents $129,345 $102,495 Short-term investments 7,383 - Accounts receivable, net 37,318 40,438 Inventories, net 125,339 99,553 Other current assets 3,029 4,866 Property, plant and equipment, net 255,651 265,900 Deferred tax asset 20,936 38,356 Long-term investments 4,197 11,336 Goodwill and other, net 95,110 83,037 ------ ------ Total assets $678,308 $645,981 ======= ======= Liabilities and stockholders' equity: Current liabilities $45,556 $47,342 Non-current liabilities 9,114 10,056 Stockholders' equity 623,638 588,583 ------- ------- Total liabilities and stockholders' equity $678,308 $645,981 ======= ======== Unaudited Condensed Consolidated Cash Flow Data Nine months ended July 31, -------------------------- 2009 2008 ---- ---- Operating activities: Net income $29,551 $27,203 Non-cash items 40,945 38,359 Changes in operating assets and liabilities, net (30,494) (3,623) ------- ------ Net cash provided by operating activities 40,002 61,939 ------ ------ Investing activities: Sale (purchase) of investments and marketable securities, net 100 (10,850) Expenditures for property, plant and equipment (6,733) (5,587) Capitalization of intangible assets (6,129) (3,208) ------ ------ Net cash used in investing activities (12,762) (19,645) ------- ------- Financing activities: Repayments of notes payable and other long-term obligations, net (88) (8,888) (Payments) proceeds from equity transactions, net (302) 7,243 ---- ----- Net cash used in financing activities (390) (1,645) ---- ------ Net change in cash and cash equivalents 26,850 40,649 Cash and cash equivalents, beginning of period 102,495 16,973 ------- ------ Cash and cash equivalents, end of period $129,345 $57,622 ======== ======

Martek Biosciences Corporation

CONTACT: Kyle Stults, Investor Relations, +1-410-740-0081,
kstults@martek.com

Web Site: http://www.martek.com/

SAIC Announces Financial Results for Second Quarter of Fiscal Year 2010- Revenues: Up 8 percent (7 percent internal) to $2.75 billion - Operating Income: Up 17 percent to $221 million - Diluted EPS from Continuing Operations: Up 19 percent to $0.31 - Reaffirming guidance for fiscal year 2010

SAN DIEGO and MCLEAN, Va., Sept. 2 /PRNewswire-FirstCall/ -- SAIC, Inc. , a scientific, engineering, and technology applications company, today announced financial results for the second quarter of fiscal year 2010, which ended July 31, 2009.

"SAIC delivered another quarter of solid program execution and financial performance in the second quarter of fiscal year 2010," said Ken Dahlberg, SAIC chairman and chief executive officer. "As we look forward to the transition to Walt Havenstein's leadership later this month, the company's employees and capabilities have created a strong foundation for continued growth."

Summary Operating Results

Revenues for the quarter were $2.75 billion, up 8 percent from $2.55 billion in the second quarter of fiscal year 2009. Internal, or non-acquisition, growth represented 7 percentage points of the consolidated growth for the quarter. Key drivers of internal growth included recent wins in defense logistics, information technology, and cyber-security as well as increased tasking on existing defense programs.

Operating income for the quarter was $221 million (8.0 percent of revenue), up 17 percent from $189 million (7.4 percent of revenue) in the second quarter of fiscal year 2009. Growth in quarterly operating income margin percentage was driven by continued improvements in cost efficiency and program performance. Income from continuing operations for the quarter was $125 million, up 19 percent from $105 million in the second quarter of fiscal year 2009. Income from continuing operations benefited from a year-over-year improvement in the effective tax rate from 40.7 percent to 38.1 percent.

Diluted earnings per share (EPS) from continuing operations for the quarter were $0.31, up 19 percent from $0.26 in the second quarter of fiscal year 2009, driven by the increase in income from continuing operations and a lower share count compared to the prior year quarter. The diluted share count for the quarter was 388 million, down 3 percent from 400 million in the second quarter of fiscal year 2009, due primarily to share repurchases made over the last four quarters. Diluted earnings per share, which include discontinued operations, were $0.31 for the quarter, up 15 percent from $0.27 in the second quarter of fiscal year 2009.

Cash Generation and Capital Deployment

Cash flow from operations for the quarter was $109 million (or 0.9 times income from continuing operations) compared to $230 million in the second quarter of fiscal year 2009. The drop in cash flow from operations primarily resulted from an additional payroll cycle in the current quarter, accounting for approximately $150 million of the year-over-year difference. Cash collections continued to be strong as days sales outstanding were 64 days, an improvement of four days sequentially and two days year-over-year.

The company acquired Atlan, Inc., a small cyber-security product testing firm, during the quarter. In addition, the company acquired R.W. Beck Group, Inc., a leading provider of business and technical consulting services in engineering, energy and infrastructure, after the close of the second quarter.

During the quarter, the company used $53 million to repurchase approximately 3 million shares including 2 million under the company's stock repurchase program and the remainder in recurring repurchases from employees in settlement of withholding taxes associated with stock option exercises and vesting events. Whether any future repurchases are made and the timing and actual number of shares repurchased under the stock repurchase program will depend on a variety of factors, including share price, corporate capital requirements, and other market conditions. As of July 31, 2009, the company had $951 million in cash and cash equivalents and $1.1 billion in long-term debt.

New Business Awards

Net new business bookings totaled $2.3 billion in the second quarter, representing a book-to-bill ratio of 0.8, reflecting an industry-wide slow down in contract awards and an increase in proposals awaiting adjudication. Net bookings are calculated as the period's ending backlog plus the period's revenue less the prior period's ending backlog and backlog obtained in acquisitions. No bookings value is assigned unless the company has received a signed contract for a priced statement of work.

Large, competitive definite delivery contract awards received during the quarter include:

-- Mine Resistant Ambush Protected (MRAP) Joint Logistics Integrator (JLI) Support. SAIC was awarded a thirty-month, $357 million task order to provide JLI and operational readiness services for MRAP vehicles in Iraq, Afghanistan, and Kuwait. SAIC will provide logistics planning, management, and analytical support to maximize fleet readiness and sustainment. -- Army Chief Information Officer (CIO) Support. Under a three-year, $55 million task order, SAIC will provide technical, analytical, and management support services to the U.S. Army's CIO in the areas of enterprise architecture, portfolio management, strategy and technology assessment and operations. -- Army Director of Information Management (DOIM) Support. SAIC received a five-year, $30 million task order from the U.S. Army's DOIM at Fort Polk, La., to provide a variety of information technology and network support services, including information assurance; automation and network support; and telephone, wireless and data communications services.

In addition, SAIC also won several indefinite-delivery/indefinite-quantity (IDIQ) contracts that are not included in net bookings. The most notable IDIQ awards during the quarter were:

-- U.S. Department of Homeland Security (DHS) National Communications System (NCS) Support. SAIC was awarded a prime contract by the U.S. DHS Office of Cybersecurity and Communication to provide scientific, engineering and technical services in support of the NCS, a cornerstone of the country's ability to provide key communications services to support government functions during emergencies. The new multiple-award contract has a five-year period of performance and a combined ceiling value of $388 million for all awardees. -- U.S. Joint Forces Command (USJFCOM) Joint Concept Development and Experimentation Directorate (J-9) Support. SAIC was awarded a five-year, $284 million contract by USJFCOM J-9 to provide research, development, engineering and technical services. Under the contract, SAIC will conduct studies and simulation, and provide concept definition, research, analysis and technological assessments. -- Space and Naval Warfare (SPAWAR) Systems Center Atlantic Support. SAIC was awarded a prime contract by SPAWAR to provide command and control integration support. The multiple-award contract has a five-year period of performance and a potential value of more than $196 million. SAIC will provide engineering and technical support services for the development, test and evaluation, and life cycle support of command, control, communications, computer, intelligence, surveillance and reconnaissance systems and related equipment and subsystems.

The company's backlog of signed business orders at the end of the second quarter of fiscal year 2010 was $16.3 billion, of which $5.6 billion was funded. As compared to the end of the second quarter of fiscal year 2009, total backlog increased 2 percent and funded backlog increased 4 percent. The negotiated unfunded backlog of $10.7 billion is the estimated amount to be earned in the future from negotiated contracts for which funding has not been authorized and priced but unexercised contract options. Negotiated unfunded backlog does not include any estimate of future expected task orders to be awarded under IDIQ or other master agreement contract vehicles.

Forward Guidance

The company currently expects to achieve all of its long-term financial goals in fiscal year 2010:

-- Growing revenue internally in the six percent to nine percent range; -- Improving operating income margin by 20 to 30 basis points until reaching a sustainable level between eight percent and nine percent; and -- Growing earnings per share from 11 percent to 18 percent.

Mark Sopp, SAIC chief financial officer commented, "The company's continued strong execution enables us to reaffirm our expectation that we will achieve our long-term financial growth goals again in fiscal year 2010. We are positioned to see increased contract awards in the second half of the year, which should provide a strong foundation as we head into fiscal year 2011."

About SAIC

SAIC is a FORTUNE 500 scientific, engineering, and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure, and health. The company's approximately 45,000 employees serve customers in the U.S. Department of Defense, the intelligence community, the U.S. Department of Homeland Security, other U.S. Government civil agencies and selected commercial markets. SAIC had annual revenues of $10.1 billion for its fiscal year ended January 31, 2009. For more information, visit http://www.saic.com/.

SAIC: From Science to Solutions Forward-Looking Statements

Certain statements in this release contain or are based on "forward-looking" information within the meaning of the Private Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as "expects," "intends," "plans," "anticipates," "believes," "estimates," "guidance" and similar words or phrases. Forward-looking statements in this release include, among others, estimates of future revenues, earnings, backlog, outstanding shares and cash flows. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Actual performance and results may differ materially from the guidance and other forward-looking statements made in this release depending on a variety of factors, including: changes in the U.S. Government defense budget or budgetary priorities or delays in the U.S. budget process; changes in U.S. Government procurement rules and regulations; our compliance with various U.S. Government and other government procurement rules and regulations; the outcome of U.S. Government reviews, audits and investigations of our company; our ability to win contracts with the U.S. Government and others; our ability to attract, train and retain skilled employees; our ability to maintain relationships with prime contractors, subcontractors and joint venture partners; our ability to obtain required security clearances for our employees; our ability to accurately estimate costs associated with our firm-fixed-price and other contracts; resolution of legal and other disputes with our customers and others; our ability to successfully acquire and integrate businesses; our ability to manage risks associated with our international business; our ability to compete with others in the markets in which we operate; and our ability to execute our business plan effectively and to overcome these and other known and unknown risks that we face. These are only some of the factors that may affect the forward-looking statements contained in this release. For further information concerning risks and uncertainties associated with our business, please refer to the filings we make from time to time with the SEC, including the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Legal Proceedings" sections of our latest annual report on Form 10-K and quarterly report on Form 10-Q, which may be viewed or obtained through the Investor Relations section of our Web site at http://www.saic.com/.

All information in this release is as of September 2, 2009. SAIC expressly disclaims any duty to update the guidance or any other forward-looking statement provided in this release to reflect subsequent events, actual results or changes in the company's expectations. SAIC also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.

CONTACTS: Investor Relations: Stuart Davis 703-676-2283 stuart.davis@saic.com Media Relations: Laura Luke Melissa Koskovich 703-676-6533 703-676-6762 laura.luke@saic.com melissa.l.koskovich@saic.com SAIC, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited, in millions, except per share amounts) Three Months Six Months Ended Ended July 31 July 31 ------- ------- 2009 2008 2009 2008 ---- ---- ---- ---- Revenues $2,749 $2,554 $5,398 $4,921 Costs and expenses: Cost of revenues 2,369 2,200 4,664 4,252 Selling, general and administrative expenses 159 165 309 306 --- --- --- --- Operating income 221 189 425 363 Non-operating income (expense): Interest income - 6 1 14 Interest expense (19) (21) (38) (40) Other income, net - 3 3 11 -- -- -- -- Income from continuing operations before income taxes 202 177 391 348 Provision for income taxes (77) (72) (149) (138) --- --- ---- ---- Income from continuing operations 125 105 242 210 Discontinued operations: Loss from discontinued operations before income taxes (3) (5) (4) (8) Benefit for income taxes 1 9 1 10 -- -- -- -- Income (loss) from discontinued operations (2) 4 (3) 2 -- -- -- -- Net income $123 $109 $239 $212 ==== ==== ==== ==== Earnings per share (a): Basic: Income from continuing operations $0.32 $0.26 $0.60 $0.51 Income (loss) from discontinued operations (0.01) 0.01 - 0.01 ----- ---- -- ---- $0.31 $0.27 $0.60 $0.52 ===== ===== ===== ===== Diluted: Income from continuing operations $0.31 $0.26 $0.60 $0.50 Income (loss) from discontinued operations - 0.01 (0.01) 0.01 -- ---- ----- ---- $0.31 $0.27 $0.59 $0.51 ===== ===== ===== ===== Weighted average shares outstanding: Basic 384 392 388 397 === === === === Diluted 388 400 392 405 === === === === (a) FASB Staff Position (FSP) No. EITF 03-6-1, "Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities" requires an allocation of income from continuing operations and net income to the Company's unvested stock awards which are considered participating securities in accordance with the FSP. The Company apportioned $4 million and $8 million of income from each of continuing operations and net income for the three and six months ended July 31, 2009, respectively, to unvested stock awards for the purposes of calculating earnings per share. Comparative amounts for the three and six months ended July 31, 2008 were $3 million and $6 million, respectively. The Company's unvested stock awards are excluded from weighted average shares outstanding. SAIC, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in millions) July 31, January 31, 2009 2009 ---- ---- ASSETS Current assets: Cash and cash equivalents $951 $936 Receivables, net 1,964 1,889 Inventory, prepaid expenses and other current assets 327 385 Assets of discontinued operations - 7 -- -- Total current assets 3,242 3,217 Property, plant and equipment, net 385 357 Intangible assets, net 75 88 Goodwill 1,260 1,249 Deferred income taxes 83 86 Other assets 59 51 -- -- $5,104 $5,048 ====== ====== LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued liabilities $1,173 $1,178 Accrued payroll and employee benefits 477 487 Notes payable and long-term debt, current portion 3 17 Liabilities of discontinued operations - 1 -- -- Total current liabilities 1,653 1,683 Notes payable and long-term debt, net of current portion 1,103 1,099 Other long-term liabilities 192 182 Stockholders' equity: Preferred stock, $.0001 par value, 1.5 billion shares authorized, 189 million and 196 million shares issued and outstanding at July 31, 2009 and January 31, 2009, respectively - - Common stock, $.0001 par value, 2 billion shares authorized, 209 million and 210 million shares issued and outstanding at July 31, 2009 and January 31, 2009, respectively - - Additional paid-in capital 2,025 1,950 Retained earnings 173 183 Accumulated other comprehensive loss (42) (49) --- --- Total stockholders' equity 2,156 2,084 ----- ----- $5,104 $5,048 ====== ====== SAIC, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited, in millions) Three Months Six Months Ended Ended July 31 July 31 ------- ------- 2009 2008 2009 2008 ---- ---- ---- ---- Cash flows from operations: Net income $123 $109 $239 $212 Loss (income) from discontinued operations 2 (4) 3 (2) Adjustments to reconcile net income to net cash provided by operations: Depreciation and amortization 22 22 44 44 Stock-based compensation 26 26 51 45 Excess tax benefits from stock-based compensation (1) (16) (14) (43) Impairment losses 1 - 1 - Other items 2 3 1 (3) Increase (decrease) in cash and cash equivalents, excluding effects of acquisitions and divestitures, resulting from changes in: Receivables 54 55 (70) 17 Inventory, prepaid expenses and other current assets (29) (12) 11 (45) Deferred income taxes 1 1 1 - Other assets 3 (4) 4 (8) Accounts payable and accrued liabilities (49) (9) (13) 10 Accrued payroll and employee benefits (32) 94 (8) - Income taxes payable (15) (34) 18 13 Other long-term liabilities 1 (1) 4 4 -- -- -- -- Total cash flows provided by operations 109 230 272 244 Cash flows from investing activities: Expenditures for property, plant and equipment (16) (13) (28) (25) Acquisition of businesses, net of cash acquired (9) (65) (9) (200) Net receipts (payments) for purchase price adjustments related to prior year acquisitions 8 (1) 8 (3) Other (1) 4 10 12 -- -- -- -- Total cash flows used in investing activities (18) (75) (19) (216) Cash flows from financing activities: Payments on notes payable and long- term debt (1) (8) (16) (110) Sales of stock and exercises of stock options 14 22 34 50 Repurchases of stock (53) (157) (276) (416) Excess tax benefits from stock-based compensation 1 16 14 43 Other - (1) - (1) -- -- -- -- Total cash flows used in financing activities (39) (128) (244) (434) -- --- --- --- Increase (decrease) in cash and cash equivalents from continuing operations 52 27 9 (406) -- -- -- --- Cash flows from discontinued operations: Cash provided by (used in) operating activities of discontinued operations - 6 (1) 7 Cash provided by (used in) investing activities of discontinued operations (3) (3) 2 (5) -- -- -- -- Increase (decrease) in cash and cash equivalents from discontinued operations (3) 3 1 2 -- -- -- -- Effect of foreign currency exchange rate changes on cash and cash equivalents 4 - 5 - -- -- -- -- Total increase (decrease) in cash and cash equivalents 53 30 15 (404) -- -- -- --- Cash and cash equivalents at beginning of period 898 662 936 1,096 --- --- --- ----- Cash and cash equivalents at end of period $951 $692 $951 $692 ==== ==== ==== ==== SAIC, INC. INTERNAL REVENUE GROWTH PERCENTAGE CALCULATIONS (NON-GAAP RECONCILIATION) (Unaudited, in millions) In this release, we refer to internal revenue growth percentage, which is a non-GAAP financial measure that may be required to be reconciled to the most directly comparable GAAP financial measure. We calculate our internal revenue growth percentage by comparing our reported revenue for the current year period to the revenue for the prior year period adjusted to include the actual revenue of acquired businesses for the comparable prior year period before acquisition. This calculation has the effect of adding revenue for the acquired businesses for the comparable prior year period to our prior year period reported revenue. We use internal revenue growth percentage as an indicator of how successful we are at growing our base business and how successful we are at growing the revenues of the businesses that we acquire. Achievement of revenue targets based on internal revenue growth is also a measure used, in part, for determining incentive compensation for our executives and the broader employee population. The limitation of this non-GAAP financial measure as compared to the most directly comparable GAAP financial measure is that internal revenue growth percentage is one of two components of the total revenue growth percentage, which is the most directly comparable GAAP financial measure. We address this limitation by presenting the total revenue growth percentage next to or near disclosures of internal revenue growth percentage. This financial measure is not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. The method that we use to calculate internal revenue growth percentage is not necessarily comparable to similarly titled financial measures presented by other companies. Internal revenue growth percentages for the three and six months ended July 31, 2009 were calculated as follows: Three Months Six Months Ended Ended July 31, July 31, 2009 2009 ---- ---- Government segment: Prior year period's revenues, as reported $2,426 $4,675 Revenues of acquired businesses for the comparable prior year period 4 24 -- -- Prior year period's revenues, as adjusted $2,430 $4,699 Current year period's revenues, as reported 2,634 5,170 ----- ----- Internal revenue growth $204 $471 ---- ---- Internal revenue growth percentage 8% 10% -- -- Commercial segment: Prior year period's revenues, as reported $128 $246 Revenues of acquired businesses for the comparable prior year period 1 6 -- -- Prior year period's revenues, as adjusted $129 $252 Current year period's revenues, as reported 117 231 --- --- Internal revenue growth $(12) $(21) -- -- Internal revenue growth percentage (9)% (8)% -- -- Total: Prior year period's revenues, as reported $2,554 $4,921 Revenues of acquired businesses for the comparable prior year period 5 30 -- -- Prior year period's revenues, as adjusted $2,559 $4,951 Current year period's revenues, as reported 2,749 5,398 ----- ----- Internal revenue growth $190 $447 ---- ---- Internal revenue growth percentage 7% 9% -- --

SAIC, Inc.

CONTACT: Investor Relations, Stuart Davis, +1-703-676-2283,
stuart.davis@saic.com, or Media Relations, Laura Luke, +1-703-676-6533,
laura.luke@saic.com, or Melissa Koskovich, +1-703-676-6762,
melissa.l.koskovich@saic.com, all of SAIC

Web Site: http://www.saic.com/

Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism

CHADDS FORD, Pa., Sept. 2 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals announced today that it has been informed by the U.S. Food and Drug Administration (FDA) that the agency has extended its review period for its long-acting testosterone undecanoate injection for men diagnosed with hypogonadism, from Sept. 2, 2009 to Dec. 2, 2009.

While the FDA has not requested additional data, the agency has informed the company that it needs more time to complete its review of the application and finalize the risk evaluation and mitigation strategy (REMS) for this product.

"Our goal is to make this significant new treatment option available to the millions of men in the U.S. suffering from low testosterone," said David Holveck, president and chief executive officer of Endo Pharmaceuticals. "We believe our application fully supports the approval of this therapy, which will be an important step in filling a gap in testosterone therapy and improving patient care."

Endo Pharmaceuticals' long-acting testosterone undecanoate, known as Nebido outside the U.S., was licensed by Bayer Schering Pharma AG, Germany to Indevus Pharmaceuticals, a company that Endo acquired earlier this year. Nebido, discovered and developed by Bayer Schering Pharma AG, Germany, has subsequently been approved in 86 countries worldwide and is available in more than 50 countries across Europe, Asia Pacific and Latin America.

About Hypogonadism

Hypogonadism, or low testosterone, is a common yet largely under-recognized and under-treated condition. An estimated 13.8 million American men have testosterone levels characterized as below normal (testosterone <300ng/dl). Yet despite this high prevalence, only about 9 percent of men with low testosterone are treated with testosterone replacement therapy.

Low testosterone is associated with a broad range of physical, psychological and sexual symptoms including decreased energy and mood, fatigue, loss of muscle mass, decreased libido and erectile dysfunction. In addition, there is increasing evidence of the link between low testosterone and other serious medical conditions including diabetes, cardiovascular disease and metabolic syndrome.

About Endo

Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, overactive bladder, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Its products include LIDODERM , a topical patch to relieve the pain of postherpetic neuralgia; Percocet and Percodan tablets for the relief of moderate-to-moderately severe pain; FROVA tablets for the acute treatment of migraine attacks with or without aura in adults; OPANA tablets for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate; OPANA ER tablets for the relief of moderate-to-severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time; Voltaren Gel, which is owned and licensed by Novartis AG, a nonsteroidal anti-inflammatory drug indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment, such as those of the hands and the knees; SANCTURA and its XR version for treatment of overactive bladder; VANTAS for the palliative treatment of advanced prostate cancer; and SUPPRELIN LA for the treatment of early onset puberty in children. The company markets its branded pharmaceutical products to physicians in pain management, neurology, surgery, oncology, endocrinology and primary care. More information, including this and past press releases of Endo Pharmaceuticals, is available at http://www.endo.com/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the company's financial position, results of operations, market position, product development and business strategy, as well as estimates of future net sales, future expenses, future net income and future earnings per share. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "intend," "guidance" or similar expressions are forward-looking statements. Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors could affect our future financial results and could cause our actual results to differ materially from those expressed in forward-looking statements contained in this press release. These factors include, but are not limited to those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, particularly the discussion under the caption "Item 1A, RISK FACTORS" in our annual report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commission on March 2, 2009. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, we think could cause our actual results to differ materially from expected and historical results. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Endo Pharmaceuticals

CONTACT: Investors/Media, Blaine Davis, +1-610-459-7158 or Jonathan
Neely, +1-610-459-6645, or Media, Kevin M. Wiggins, +1-610-459-7281, all of
Endo Pharmaceuticals

Web Site: http://www.endo.com/

IPC The Hospitalist Company Completes New Jersey Acquisition

NORTH HOLLYWOOD, Calif., Sept. 2 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. , a leading national hospitalist physician group practice company, announced today that it has acquired Hospital Medicine Associates, P.C. (HMA). Based in Livingston, New Jersey, HMA represents IPC's second practice group in the state, following the recent acquisition of a hospitalist group in nearby Morristown. IPC expects to add approximately 25,000 patient encounters annually from the HMA acquisition.

Adam Singer, M.D., IPC's Chairman and CEO, said, "IPC initially established operations in New Jersey in June of this year and the acquisition of HMA will serve to strengthen our presence in this important market. HMA is a high-quality group of providers with skilled leadership but faced the challenges of a limited business infrastructure. Now HMA can build on our solid business platform to grow its practice and reach its full potential."

Ed Crandell, IPC's Executive Director for the region, commented, "HMA's hospitalists will continue to practice at St. Barnabas Medical Center and also provide coverage at skilled nursing and rehabilitation facilities in the surrounding area. We believe that the additional resources from IPC in areas such as recruitment, technology and quality initiatives will enable HMA to increase service levels in these facilities as well as provide opportunities for expansion to additional sites."

HMA's owner, Jaqueline Holubka M.D., will remain with the group and continue to serve as Practice Group Leader. Dr. Holubka remarked, "I look forward to continuing my career as a hospitalist with the IPC family. I've been very impressed with the quality of IPC's clinical leadership and with the company's constant attention to innovation and support of its practice groups."

About IPC The Hospitalist Company, Inc.

IPC The Hospitalist Company, Inc. is a leading national physician group practice company focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers manage the care of hospitalized patients in coordination with primary care physicians and specialists. The Company provides its hospitalists with the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of inpatient care in the facilities it serves. For more information, visit the IPC website at http://www.hospitalist.com/.

Media Contact: Investor Contacts: Scott Public Relations The Ruth Group Elaine Murphy Amy Glynn/Nick Laudico 818.610.0270 646.536.7023/7030 elaine@scottpublicrelations.com aglynn@theruthgroup.com nlaudico@theruthgroup.com

IPC The Hospitalist Company, Inc.

CONTACT: Media Contact: Elaine Murphy, Scott Public Relations,
+1-818-610-0270, elaine@scottpublicrelations.com; or Investor Contacts: Amy
Glynn, +1-646-536-7023, aglynn@theruthgroup.com, or Nick Laudico,
+1-646-536-7030, nlaudico@theruthgroup.com, both of The Ruth Group

Web Site: http://www.hospitalist.com/

Gentiva(R) Health Services Completes Acquisition of Home Health Agency

ATLANTA, Sept. 2 /PRNewswire-FirstCall/ -- Gentiva Health Services, Inc. , a leading provider of comprehensive home health services, announced today that it has completed its acquisition of Rush Home Care, Inc. (d/b/a Magna Home Health), a part of the Rush Health System, located in central Mississippi and west central Alabama. The purchase was funded from Gentiva's existing cash reserves.

"We extend a warm welcome to all Magna Home Health employees and anticipate a smooth transition as we enter seven new counties requiring a certificate of need to participate in the delivery of home health services," said Gentiva CEO and President Tony Strange. "We also look forward to the possibility of bringing our groundbreaking specialty home health programs and other Gentiva services to these areas as yet another way to differentiate us from the competition and build strong relationships with physicians and payers."

The acquisition is not expected to have a material impact on Gentiva's financial position or results of operations in 2009.

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is a leading provider of comprehensive home health services, delivering innovative, high quality care to patients across the United States. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; respiratory therapy and home medical equipment; infusion therapy services; and other therapies and services. For more information, visit Gentiva's web site, http://www.gentiva.com/, and its investor relations section at http://investors.gentiva.com/. GTIV-G

Forward-Looking Statement

Certain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These factors include, among others, the following: economic and business conditions, including the ability to access capital markets; demographic changes; changes in, or failure to comply with, existing governmental regulations; legislative proposals for healthcare reform; changes in Medicare and Medicaid reimbursement levels; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to natural disasters or terrorist acts; ability to successfully integrate the operations of acquisitions the Company may make and achieve expected synergies and operational efficiencies within expected time-frames; effect on liquidity of the Company's debt service requirements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended December 28, 2008.

Financial and Investor Contact: John R. Potapchuk 631-501-7035 john.potapchuk@gentiva.com or Brandon Ballew 770-221-6700 brandon.ballew@gentiva.com Media Contact: Scott Cianciulli Brainerd Communicators 212-986-6667 cianciulli@braincomm.com

Gentiva Health Services, Inc.

CONTACT: Financial and Investors: John R. Potapchuk, +1-631-501-7035,
john.potapchuk@gentiva.com, or Brandon Ballew, +1-770-221-6700,
brandon.ballew@gentiva.com, both of Gentiva Health Services, Inc; Media: Scott
Cianciulli, Brainerd Communicators, +1-212-986-6667, cianciulli@braincomm.com

Web Site: http://www.gentiva.com/

Company News On-Call: http://www.prnewswire.com/comp/657293.html

Mercury Computer Systems to Present at the Kaufman Brothers 12th Annual Investor Conference on September 9, 2009

CHELMSFORD, Mass., Sept. 2 /PRNewswire-FirstCall/ -- Mercury Computer Systems, Inc. , a leading provider of embedded, high-performance computing systems and software for image, sensor, and signal processing applications, announced that it will present at the Kaufman Brothers 12th Annual Investor Conference to be held on September 9-11, 2009, at the W Hotel in New York, New York. On Wednesday, September 9, at 2:30 pm EDT, management will present an overview of the Company's business.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081013/NEM013LOGO )

An audio webcast and archive of the event will be available on Wednesday, September 9, at 2:30 pm EDT through the Company's website at http://www.mc.com/investor under "Financial Events." A replay of the webcast will be archived for three months on the Company's website under "Financial Events."

Mercury Computer Systems, Inc. - Where Challenges Drive Innovation(TM)

Mercury Computer Systems (http://www.mc.com/, Nasdaq: MRCY) provides embedded computing systems and software that combine image, signal, and sensor processing with information management for data-intensive applications. With deep expertise in optimizing algorithms and software and in leveraging industry-standard technologies, we work closely with customers to architect comprehensive, purpose-built solutions that capture, process, and present data for defense electronics, homeland security, and other computationally challenging commercial markets. Our dedication to performance excellence and collaborative innovation continues a 25-year history in enabling customers to gain the competitive advantage they need to stay at the forefront of the markets they serve.

Mercury is based in Chelmsford, Massachusetts, and serves customers worldwide through a broad network of direct sales offices, subsidiaries, and distributors.

Contact: Robert Hult, CFO, Mercury Computer Systems, Inc. 978-967-1990

Challenges Drive Innovation is a trademark of Mercury Computer Systems, Inc. Other product and company names mentioned may be trademarks and/or registered trademarks of their respective holders.

Photo: http://www.newscom.com/cgi-bin/prnh/20081013/NEM013LOGO
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk photodesk@prnewswire.com Mercury Computer Systems, Inc.

CONTACT: Robert Hult, CFO, Mercury Computer Systems, Inc.,
+1-978-967-1990

Web Site: http://www.mc.com/

Superior Energy Services, Inc. to Present at the Barclays 2009 CEO Energy/Power Conference

NEW ORLEANS, Sept. 2 /PRNewswire-FirstCall/ -- Superior Energy Services, Inc. today announced that Terence Hall, Chairman and Chief Executive Officer, will present at the Barclays 2009 CEO Energy/Power Conference to be held in New York City on September 9 - 10, 2009.

Superior Energy's presentation will be webcast live on Wednesday, September 9, 2009 at 4:25 p.m. Eastern Time. To listen to the audio webcast and view accompanying presentation materials, visit the Investor Relations section of Superior Energy's website at http://www.superiorenergy.com/. A replay will be archived on the site shortly after the presentation concludes.

Superior Energy Services, Inc. serves the drilling and production needs of oil and gas companies worldwide through its brand name rental tools and its integrated well intervention services and tools, supported by an engineering staff who plan and design solutions for customers. Offshore projects are delivered by the Company's fleet of modern marine assets.

FOR FURTHER INFORMATION CONTACT: Greg Rosenstein, VP of Investor Relations, 504-362-4321 Ben Burnham, AVP, DRG&E, 713-529-6600

Superior Energy Services, Inc.

CONTACT: Greg Rosenstein, VP of Investor Relations of Superior Energy
Services, Inc., +1-504-362-4321; or Ben Burnham, AVP of DRG&E,
+1-713-529-6600, for Superior Energy Services, Inc.

Web Site: http://www.superiorenergy.com/

American Software Reports Preliminary First Quarter of Fiscal Year 2010 ResultsCompany achieves 34th consecutive quarter of profitability, License Fee Revenues increase 51%, Adjusted Net Earnings increase 155%

ATLANTA, Sept. 2 /PRNewswire-FirstCall/ -- American Software, Inc. today reported financial results for the first quarter of fiscal year 2010, achieving 34 consecutive quarters of profitability.

Key first quarter financial highlights include: -- Adjusted net earnings for the quarter ended July 31, 2009, were $2.0 million or $0.08 per fully diluted share, an increase of 155% over the first quarter last year; -- GAAP net earnings for the quarter ended July 31, 2009 were $1.2 million or $0.05 per fully diluted share, an increase of 94% over the first quarter last year; -- Total revenues for the quarter ended July 31, 2009 were $17.8 million, a decrease of 7% over the first quarter of fiscal 2009; -- Software license fees for the quarter ended July 31, 2009 were $4.1 million, an increase of 51% over the first quarter of fiscal 2009; -- Services and other revenues for the first quarter ended July 31, 2009 were $6.9 million, a decrease of 26% from the first quarter of fiscal 2009; -- Maintenance revenues for the quarter ended July 31, 2009 were $6.8 million, a decrease of 4% from the first quarter of fiscal 2009; -- Operating earnings for the quarter ended July 31, 2009 were $1.5 million, a increase of 14% from the first quarter of fiscal 2009; and -- Completion of the tender offer for the shares of Logility, Inc. not owned by American Software for $7.02 per share, and the follow-on merger of Logility into a wholly-owned subsidiary of American Software on July 9, 2009.

Adjusted net earnings for the quarter ended July 31, 2009, which excludes stock-based compensation expense, acquisition-related amortization of intangibles, stock-based compensation related to the Logility tender offer and expenses related to the Logility tender offer, were $2.0 million or $0.08 per fully diluted share, compared to $795,000 or $0.03 per fully diluted share for the same period last year, which excluded stock-based compensation expenses and acquisition-related amortization of intangibles.

The Company is including adjusted net earnings and adjusted net earnings per share in the summary financial information provided with this press release as supplemental information relating to its operating results. This financial information is not in accordance with, or an alternative for, GAAP and may be different from non-GAAP net earnings and non-GAAP per share measures used by other companies. The Company believes that this presentation of adjusted net earnings and adjusted net earnings per share provides useful information to investors regarding certain additional financial and business trends relating to its financial condition and results of operations.

The overall financial condition of the Company remains strong, with cash and investments of approximately $61.0 million and no debt as of July 31, 2009. This is approximately a $10.0 million decrease when compared to April 30, 2009 due to payment for shares and related expenses associated with the Logility tender offer and the payment of approximately $2.3 million in dividends.

"The Company delivered its 34th consecutive quarter of profitability despite the uncertain economic environment. Adjusted net earnings increased approximately $1.2 million or 155% when compared to the same period last year. In July, we successfully completed the tender offer for the publicly held shares of Logility and anticipate realizing considerable cost savings from operating only one public company," stated James C. Edenfield, president and CEO of American Software. "American Software is focused on demand-driven enterprise solutions and world-class supply chain management capabilities," said Edenfield. "Our applications help companies reduce costs, increase market share, forecast more accurately and boost customer service while reducing inventory. As a result, our solutions drive value for our customers in both good and bad economies."

"Our sustained profitability has continued to allow the Company to provide a tangible benefit to our shareholders with a quarterly dividend as well as a share repurchase program," continued Edenfield. "On August 17, 2009 our Board of Directors authorized the Company's next quarterly dividend of $0.09 per common share, which is payable on December 1, 2009 to shareholders of record at the close of business on November 19, 2009."

Additional highlights for the first quarter of fiscal year 2010 include: Customers and Channels: -- Notable new and existing customers placing orders with the Company in the first quarter include: Arrow Fastener Co., Boston Apparel Group, Bush Hog, Cache, Carlisle Tire & Wheel, Central Garden and Pet, DCI Cheese, Hanesbrands, Inc., Juicy Couture, Johnstone Supply, KGP Telecommunications, Stony Apparel Corp., Synergy Health Ltd., and WinWholesale. -- During the quarter, software license agreements were signed with customers located in 6 countries including: Australia, South Africa, the Netherlands, Turkey, the United Kingdom and the United States. -- Logility, a wholly-owned subsidiary of the Company, announced that Rockline Industries expanded its deployment of Logility Voyager Solutions(TM) to improve demand visibility and optimize inventory, manufacturing and sales and operations planning (S&OP). Rockline chose to expand their Logility Voyager Solutions footprint after achieving reduced costs and improved visibility throughout their transportation operations as a result of their implementation of Logility Voyager Transportation Planning and Management. -- NGC (New Generation Computing ), a wholly-owned subsidiary, announced that Billabong has selected NGC's e-PLM for Product Lifecycle Management and e-SPS for Global Sourcing and Visibility. NGC's software will be implemented worldwide as a strategic PLM and global sourcing solution for Billabong across all of the company's regions and brands. Products and Technology: -- Demand Management, a wholly-owned subsidiary of Logility, announced that its Demand Solutions supply chain management software has been Certified for Microsoft Dynamics, which is Microsoft Corp.'s highest standard for partner-developed software. The Demand Solutions suite now carries the distinct Certified for Microsoft Dynamics logo. -- Demand Management announced that Demand Solutions was awarded the customer-nominated "Great Supply Chain Partner 2009" from Supply Chain Brain. -- During the quarter, Logility, Demand Management, and New Generation Computing were named winners of the Supply & Demand Chain Executive Magazine 2009 Supply & Demand Chain Executive 100, "Supply Chain Saves the Enterprise" award. The 2009 Supply & Demand Chain Executive 100 awards supply chain solution and service providers that are helping their customers and clients through the down economy while positioning them for profitable growth in the future. -- NGC announced that Inbound Logistics Magazine has selected NGC as one of the Top 100 Logistics IT Companies for the second consecutive year. This prestigious recognition is designed to provide supply chain and logistics executives with a complete guide to the industry's best-in-class technology and service providers. -- Logility was featured along with Consumer Goods Technology magazine in an important APICS webcast "The Road to S&OP Success." The webcast focused on the complex journey to S&OP success and the outstanding results that demand-driven companies are achieving as a result of streamlining their S&OP process including improvements in revenue, an increase in commercialization reliability and reduction in inventory. About American Software, Inc.

Headquartered in Atlanta, American Software develops, markets and supports one of the industry's most comprehensive offerings of integrated business applications, including supply chain management, Internet commerce, financial, warehouse management and manufacturing solutions. e-Intelliprise(TM) is an ERP/supply chain management suite, which leverages Internet connectivity and includes multiple manufacturing methodologies. Logility, Inc., a wholly-owned subsidiary of American Software, is a leading provider of collaborative supply chain solutions that help small, medium, large and Fortune 1000 companies realize substantial bottom-line results in record time with its Logility Voyager Solutions(TM) and Demand Solutions product suites. Logility is proud to serve such customers as Arch Chemicals, Avery Dennison Corporation, BP (British Petroleum), McCain Foods, Pernod Ricard and Sigma Aldrich. New Generation Computing Inc. (NGC), a wholly-owned subsidiary of American Software, is a leading provider of PLM, Global Sourcing and ERP solutions for fashion, apparel, footwear and retail. Headquartered in Miami, NGC's global customers include VF Corporation, A|X Armani Exchange, Carter's, Maggy London, R.G. Barry, Hugo Boss, Dick's Sporting Goods, Isda & Co., Tristan America, Parigi Group and many others. For more information on the Company, contact: American Software, 470 East Paces Ferry Rd., Atlanta, GA 30305; (800) 726-2946 or (404) 261-4381. FAX: (404) 264-5206. INTERNET: http://www.amsoftware.com/ or e-mail: ask@amsoftware.com.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to substantial risks and uncertainties. There are a number of factors that could cause actual results to differ materially from those anticipated by statements made herein. These factors include, but are not limited to, changes in general economic conditions, technology and the market for the Company's products and services, including economic conditions within the e-commerce markets; the timely availability and market acceptance of these products and services; the Company's ability to satisfy in a timely manner all SEC required filings and the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 and the rules and regulations adopted under that Section; the challenges and risks associated with integration of acquired product lines and companies; the effect of competitive products and pricing; the uncertainty of the viability and effectiveness of strategic alliances; and the irregular pattern of the Company's revenues. For further information about risks the Company could experience as well as other information, please refer to the Company's Form 10-K for the year ended April 30, 2009 and other reports and documents subsequently filed with the Securities and Exchange Commission. For more information, contact: Vincent C. Klinges, Chief Financial Officer, American Software, Inc., (404) 264-5477 or fax: (404) 237-8868.

e-Intelliprise is a trademark of American Software, Logility is a registered trademark and Logility Voyager Solutions is a trademark of Logility, Demand Solutions is a registered trademark of Demand Management, and NGC and New Generation Computing are registered trademarks and REDHORSE is a trademark of New Generation Computing. Other products mentioned in this document are registered, trademarked or service marked by their respective owners.

AMERICAN SOFTWARE, INC. Consolidated Statements of Operations Information (In thousands, except per share data) (Unaudited) First Quarter Ended ------------------- July 31, Pct 2009 2008 Chg. ---- ---- ---- Revenues: License $4,144 $2,742 51% Services & other 6,873 9,331 (26%) Maintenance 6,817 7,125 (4%) ----- ----- --- Total Revenues 17,834 19,198 (7%) ------ ------ --- Cost of Revenues: License 856 1,288 (34%) Services & other 4,624 6,008 (23%) Maintenance 1,711 1,814 (6%) Total Cost of Revenues 7,191 9,110 (21%) ----- ----- --- Gross Margin 10,643 10,088 6% ------ ------ --- Operating expenses: Research and development 2,229 2,336 (5%) Less: capitalized development (559) (507) 10% Sales and marketing 3,700 3,796 (3%) General and administrative 3,821 3,094 23% Recovery of doubtful accounts (320) - nm Acquisition related amortization of intangibles 88 88 0% Stock option compensation charge related to the Logility tender offer 230 - nm ----- ----- --- Total Operating Expenses 9,189 8,807 4% ----- ----- --- Operating Earnings 1,454 1,281 14% ----- ----- --- Interest Income (Expense) & Other, Net 618 (136) nm --- ---- --- Earnings Before Income Taxes and Noncontrolling Interest 2,072 1,145 81% Income Tax Expense 801 448 79% --- --- --- Net Earnings $1,271 $697 82% ------ ---- --- Noncontrolling Interest Expense 90 87 3% --- --- --- Net Earnings attributable to American Software, Inc. $1,181 $610 94% ====== ==== === Earnings per common share: (1) Basic $0.05 $0.02 150% ===== ===== === Diluted $0.05 $0.02 150% ===== ===== === Weighted average number of common shares outstanding: Basic 25,302 25,393 Diluted 25,741 25,984 Reconciliation of Adjusted Net Earnings: Net Earnings $1,181 $610 Acquisition-related amortization of intangibles (2) 54 54 Stock-based compensation (2) 112 131 Stock option compensation charge related to the Logility tender offer (2) 141 - Expenses related to the Logility tender offer (3) 543 - --- --- Adjusted Net Earnings $2,031 $795 155% ====== ==== === Adjusted Net Earnings per Diluted Share $0.08 $0.03 167% ===== ===== === (1) - Basic per share amounts are the same for Class A and Class B shares. Diluted per share amounts for Class A shares are shown above. Diluted per share for Class B shares under the two-class method are $0.05 and $0.02 for the three months ended July 31, 2009 and 2008, respectively. (2) - Tax affected using the effective tax rate for the three month period ended July 31, 2009 and 2008. (3) - Not tax affected due to no tax deduction recorded on these expenses nm- not meaningful AMERICAN SOFTWARE, INC. Consolidated Balance Sheet Information (In thousands) (Unaudited) July 31, April 30, 2009 2009 ------ ------ Cash and Short-term Investments $45,064 $54,000 Accounts Receivable: Billed 10,212 10,234 Unbilled 3,000 2,995 ----- ----- Total Accounts Receivable, net 13,212 13,229 Prepaids & Other 2,445 2,886 Deferred Tax Asset 280 246 --- --- Current Assets 61,001 70,361 Investments - Non-current 15,972 17,094 PP&E, net 7,100 7,189 Capitalized Software, net 5,278 4,859 Goodwill 11,709 11,709 Other Intangibles, net 836 950 Other Non-current Assets 145 157 --- --- Total Assets $102,041 $112,319 ======== ======== Accounts Payable $1,138 $822 Accrued Compensation and Related costs 1,752 2,374 Dividend Payable 2,278 2,277 Accrued Tender Offer Payable 3,073 - Other Current Liabilities 3,217 3,355 Deferred Revenues 15,651 16,101 ------ ------ Current Liabilities 27,109 24,929 Deferred Tax Liability - long term 1,163 1,163 American Software's Shareholders' Equity 73,769 79,839 Noncontrolling Interest in subsidiary - 6,388 ----- ----- Total Shareholders' Equity 73,769 86,227 -------- -------- Total Liabilities & Shareholders' Equity $102,041 $112,319 ======== ========

American Software, Inc.

CONTACT: Vincent C. Klinges, Chief Financial Officer of American
Software, Inc., +1-404-264-5477

Web Site: http://www.amsoftware.com/

Abbott to Acquire Visiogen, Expanding Vision Care PortfolioProvides Abbott with Next-Generation Cataract Technology to Address Presbyopia

ABBOTT PARK, Ill. and IRVINE, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Abbott announced today a definitive agreement to acquire Visiogen, Inc. for $400 million in cash, providing the company with a next-generation accommodating intraocular lens (IOL) technology to address presbyopia for cataract patients.

Visiogen, a privately held company based in Irvine, Calif., with European operations in Karlsruhe, Germany, is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts.

"This acquisition demonstrates Abbott's continued commitment to vision care and our desire to introduce and accelerate technologies that have the ability to make a difference in the lives of millions of people around the world," said John M. Capek, executive vice president, Medical Devices, Abbott. "Combining Visiogen's accommodating lens technology with Abbott's existing medical optics portfolio expands our ability to offer a diverse set of refractive options to our ophthalmic customers and the patients they serve."

"We are thrilled to join forces with Abbott to bring this much-anticipated technology to market," said Reza Zadno, founder, CEO and president of Visiogen, Inc. "The global clinical results with Synchrony are extremely encouraging, and the opportunity to leverage Abbott Medical Optics' extensive commercialization infrastructure means that many more patients will benefit from this exciting advancement in cataract and presbyopia correction."

Visiogen's accommodating IOL, called Synchrony, is designed to deliver improved vision at all distances, potentially eliminating the need for glasses or contact lenses, reducing glare and nighttime halos, and improving contrast sensitivity.

Intraocular lenses are implanted in a patient's eye after the removal of the natural lens that has become clouded by a cataract. Conventional monofocal IOLs are designed to focus primarily at a distance and not to correct presbyopia, an age-related change in vision in which the eye's lens can no longer adjust its focal length to allow clear vision at different distances. A common symptom of presbyopia is blurry close-up vision. Presbyopia usually begins after the age of 40 and is estimated to affect more than 1 billion people worldwide.

Visiogen's Synchrony accommodating IOL is a significant advancement in artificial lens technology. The unique design of the Synchrony lens is designed to mimic the eye's natural capacity to change focus (accommodation), with the potential to deliver a full range of vision. Synchrony has been implanted in more than 1,200 eyes and has been the subject of extensive clinical studies both in the U.S. and internationally. Synchrony has received CE mark designation and has been available commercially in Europe since January 2009. It also is currently under review by the U.S. Food and Drug Administration (FDA).

"Visiogen's Synchrony lens allows Abbott Medical Optics to enter the growing accommodating IOL segment and enhances our premium IOL portfolio that includes the Tecnis Multifocal lens," said Jim Mazzo, senior vice president, Abbott, and president, Abbott Medical Optics.

Abbott entered the vision care segment following its February 2009 acquisition of Advanced Medical Optics. Abbott Medical Optics offers a range of cataract, refractive and corneal products designed to meet the needs of patients who suffer from a wide range of vision disorders and seek greater freedom from the limitations of eyeglasses.

This transaction is subject to customary closing conditions and regulatory approvals and is expected to close in the fourth quarter of 2009. This transaction does not impact Abbott's previously issued earnings-per-share guidance for 2009.

J.P. Morgan Securities Inc. acted as exclusive financial advisor to Visiogen.

About Visiogen

Visiogen, Inc. is focused on developing innovative products for cataract and refractive patients. Founded in 2001 and located in Irvine, Calif., Visiogen's first commercial application, the Synchrony, a 3-dimensional, dual-optic accommodating intraocular lens and pre-loaded injector, was commercially released in Europe in 2009. The results of the U.S. IDE study, completed in 2009, are currently under review by the U.S. Food and Drug Administration (FDA). More information about Visiogen and the Synchrony accommodating IOL can be found at http://www.visiogen.com/.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 72,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com/.

Abbott Forward Looking Statement

Some statements in this news release may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. Abbott cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Abbott's operations are discussed in Item 1A, "Risk Factors," to our Annual Report on Securities and Exchange Commission Form 10-K for the year ended Dec. 31, 2008, and are incorporated by reference. Abbott undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments.

About Visiogen

Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts and presbyopia.

-- Headquarters: Irvine, Calif. -- Employees: Approx. 65 -- Founded: 2001

Synchrony Dual Optic Accommodating Intraocular Lens (IOL): Is a leading-edge ophthalmic technology, incorporating a 3-dimensional, dual-optic accommodating intraocular lens and pre-loaded injector. The device's unique physiologic design is intended to mimic the natural function of the human eye and to enable patients to see at all distances without the need for glasses or contact lenses while delivering excellent contrast sensitivity with reducing side effects (glare and halos). Synchrony has received CE mark designation and was commercially released in Europe in 2009. It is also currently under review by the U.S. Food and Drug Administration (FDA).

About Presbyopia

Presbyopia is an age-related change in vision in which the eye's lens can no longer adjust its focal length to allow clear vision at different distances. A common symptom is blurry close-up vision. This loss of flexibility accommodation usually begins after age 40. The condition is estimated to affect more than 1 billion people worldwide.

IOL Technology -- Intraocular lens (IOL): An artificial lens (usually made of acrylic or silicone) that is surgically implanted into the eye to replace the natural lens following cataract extraction. IOL technologies include: -- Monofocal IOL: Provides vision at one distance only and typically requires patient to wear reading glasses. -- Multifocal IOLs: Designed to provide vision at all distances (near, intermediate, distance) and majority of patients no longer require reading glasses. -- Accommodating IOLs: Designed to address presbyopia and loss of flexibility of natural lens due to aging by mimicking the ability of the natural lens to change focus, allowing the patient to see at all distances. Market Size -- Total current IOL market is estimated at $1.9 billion, growing to $2.7 billion by 2014*. -- Accommodating IOLs are projected to grow to $600 million by 2014 (more than 20 percent of total IOL market)*. -- In the U.S., only accommodating IOLs and multifocal IOLs are eligible for Medicare-reimbursement for correction of presbyopia. * Source: MarketScope

Abbott

CONTACT: Media, Scott Stoffel, +1-847-936-9502, or Adelle Infante,
+1-847-938-8745, or Financial, John Thomas, +1-847-938-2655, or Larry Peepo,
+1-847-935-6722; or Kevin Hykes of Visiogen, Inc., +1-949-900-3360

Web Site: http://www.abbott.com/
http://www.visiogen.com/

Patriot Coal CEO to Speak at Barclays CEO Energy/Power Conference

ST. LOUIS, Sept. 2 /PRNewswire-FirstCall/ -- Patriot Coal Corporation today announced that its Chief Executive Officer, Richard M. Whiting, will speak at the Barclays CEO Energy/Power Conference on Thursday, September 10 at 1:45 p.m. Eastern Daylight Time at the Sheraton New York Hotel & Towers.

About Patriot Coal

Patriot Coal Corporation is a leading producer and marketer of coal in the eastern United States, with 14 current mining complexes in Appalachia and the Illinois Basin. The Company ships to domestic and international electric utilities, industrial users and metallurgical coal customers, and controls approximately 1.8 billion tons of proven and probable coal reserves. The Company's common stock trades on the New York Stock Exchange under the symbol PCX.

Patriot Coal Corporation

CONTACT: Janine Orf of Patriot Coal Corporation, +1-314-275-3680,
jorf@patriotcoal.com

Web Site: http://www.patriotcoal.com/

Jinpan International Announces Completion of Shanghai Facility Ahead of Schedule

ENGLEWOOD CLIFFS, N.J., Sept. 2 /PRNewswire-FirstCall/ -- Jinpan International Ltd. , a leading designer, manufacturer and distributor of cast resin transformers for high voltage distribution equipment in China, today announced that it has completed the phase 1 renovation and construction of its Shanghai facility approximately one month ahead of schedule.

Phase 1 completion of the Shanghai facility will increase the Company's total transformer capacity by 11% from 9.0 million KVA to 10.1 million KVA and increase total production capacity for complementary power distribution products and integrated assemblies by 300% over current levels. Located in the Shanghai Qingpu Industrial Park, this site covers an area of 71,000 square meters.

Mr. Zhiyuan Li, Chief Executive Officer of Jinpan stated, "We are excited to announce the completion of the first phase of our Shanghai manufacturing facility. At the new Shanghai facility, we will focus on the production of complementary power distribution products for wind power applications and integrated assemblies such as unit substations, as well as other more highly engineered products. We look forward to our continued push into the growing market of alternative energy generation."

About Jinpan International Ltd

Jinpan International Ltd. designs, manufactures and distributes cast resin transformers for high voltage distribution equipment in China and other countries around the world. Jinpan's cast resin transformers allow high voltage transmissions of electricity to be distributed to various locations at lower, more usable voltage levels. The Company has obtained ISO9001 and ISO1401 certification of its cast resin transformers. Its principal executive offices are located in Hainan, China and its U.S. headquarters is based in Englewood Cliffs, New Jersey.

Safe Harbor Provision

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and observations and involve known and unknown risks, and uncertainties or other factors not under the Company's control, which may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations implied by these forward-looking statements. These factors include, but are not limited to, the following:

-- our ability to successfully implement our business strategy; -- the impact of existing and new competitors in the markets in which we compete, including competitors that may offer less expensive products and services, more desirable or innovative products or technological substitutes, or have more extensive resources or better financing; -- the effects of rapid technological changes and vigorous competition in the markets in which we operate; -- uncertainties about the future growth in electricity consumption and infrastructure development in the markets in which we operate; -- other factors or trends affecting the industry generally and our financial condition in particular; -- the effects of the higher degree of regulation in the markets in which we operate; -- general economic and political conditions in the countries in which we operate or other countries which have an impact on our business activities or investments; -- the monetary and interest rate policies of the countries in which we operate; -- changes in competition and the pricing environments in the countries in which we operate; -- exchange rates; and -- other factors listed from time-to-time in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 20-F for the period ended December 31, 2007 and our subsequent reports on Form 6-K.

Except as required by law, we are not under any obligation, and expressly disclaim any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise.

Jinpan International Ltd.

CONTACT: Investors, Jinpan International Ltd., Mark Du, Chief Financial
Officer, +1-201-227-0680; or ICR, Inc., In China, Yuening Jiang,
+86-10-6599-7965; or In U.S., Brian M. Prenoveau, CFA, +1-203-682-8200

Chindex International Announces September Investor Conferences Participation

BETHESDA, Md., Sept. 2 /PRNewswire-Asia/ -- Chindex International, Inc. ("Chindex") , a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced its participation in the following conferences:

-- Morgan Stanley Healthcare Corporate Day, to be held September 11, 2009 in Boston, MA. Management will meet with institutional investors throughout the day. -- Susquehanna Financial Group Third Annual Beijing Management Summit, to be held September 16-17, 2009 in Beijing, China. Roberta Lipson, Chief Executive Officer of Chindex International, will speak on a panel discussion entitled, "China Medical Device/Healthcare Services Panel," scheduled from 9:10-10:15am Beijing Time on September 17, 2009. In addition, management will also present at 10:20am Beijing Time on September 17, 2009 and meet with institutional investors throughout both days. -- Maxim Group Growth Conference, to be held September 29, 2009 at the Grand Hyatt in New York City. Management will present at 10:30am ET on September 29, 2009 and meet with institutional investors throughout the day. A live webcast will be available via the following link: http://www.wsw.com/webcast/maxim2/chdx/ .

For further details, please contact your respective institutional sales representative.

About Chindex International, Inc.

Chindex is an American healthcare company that provides healthcare services and supplies medical capital equipment, instrumentation and products to the Chinese marketplace, including Hong Kong. Healthcare services are provided through the operations of its United Family Hospitals and Clinics, a network of private primary care hospitals and affiliated ambulatory clinics in China. The Company's hospital network currently operates in the Beijing, Shanghai, Guangzhou and Wuxi. The Company sells medical products manufactured by various major multinational companies, including Siemens AG and Intuitive Surgical, for which the Company is the exclusive distribution partner for the sale and servicing of color ultrasound systems and surgical robotic systems respectively. It also arranges financing packages for the supply of medical products to hospitals in China utilizing the export loan and loan guarantee programs of both the U.S. Export-Import Bank and the German KfW Development Bank. With twenty-seven years of experience, approximately 1,300 employees, and operations in China, Hong Kong, the United States and Germany, the Company's strategy is to expand its cross-cultural reach by providing leading edge healthcare technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Company's websites http://www.chindex.com/ and http://www.unitedfamilyhospitals.com/ .

For more information, please contact: Integrated Corporate Relations Ashley M. Ammon Tel: +1-203-682-8200

Chindex International, Inc.

CONTACT: Integrated Corporate Relations, Ashley M. Ammon,
+1-203-682-8200, for Chindex International, Inc.

Web site: http://www.chindex.com/
http://www.unitedfamilyhospitals.com/
http://www.wsw.com/webcast/maxim2/chdx

SORL Auto Parts to Attend Rodman & Renshaw Annual Global Investment Conference

ZHEJIANG, Sept. 2 /PRNewswire-Asia-FirstCall/ -- SORL Auto Parts, Inc. ("SORL" or "The Company"), a leading manufacturer and distributor of commercial vehicle air brake valves as well as related auto parts in China, today announced that management will participate in the Rodman & Renshaw Annual Global Investment Conference at the New York Palace Hotel in New York, NY. The Company will present on Wednesday, September 9, 2009 at 2:50pm Eastern Time.

During the conference, management will be available to meet with analysts and portfolio managers. Interested parties and investors who wish to meet with SORL's management may contact LK@rodm.com or call (212) 430-1782. Participation in the Rodman & Renshaw Annual Global Investment Conference is by invitation only.

About SORL Auto Parts, Inc.

As China's leading manufacturer and distributor of automotive air brake valves, SORL Auto Parts, Inc. ranks first in market share in the segment for commercial vehicles weighing more than three tons, such as trucks and buses. The Company distributes products both within China and internationally under the SORL trademark. SORL ranks among the top 100 auto component suppliers in China, with a product range that includes 40 types of air brake valves and over 1000 different specifications. The Company has four authorized international sales centers in Australia, United Arab Emirates, India, and the United States, with additional offices slated to open in other locations in the near future. For more information, please visit http://www.sorl.cn/ .

Safe Harbor Statement

This press release may include certain statements that are not descriptions of historical facts, but are forward-looking statements. Forward-looking statements can be identified by the use of forward-looking terminology such as "will," "believes," "expects" or similar expressions. These forward- looking statements may also include statements about our proposed discussions related to our business or growth strategy, which is subject to change. Such information is based upon expectations of our management that were reasonable when made but may prove to be incorrect. All of such assumptions are inherently subject to uncertainties and contingencies beyond our control and upon assumptions with respect to future business decisions, which are subject to change. We do not undertake to update the forward-looking statements contained in this press release. For a description of the risks and uncertainties that may cause actual results to differ from the forward-looking statements contained in this press release, see our most recent Annual Report filed with the Securities and Exchange Commission (SEC) on Form 10-K, and our subsequent SEC filings. Copies of filings made with the SEC are available through the SEC's electronic data gathering analysis retrieval system (EDGAR) at http://www.sec.gov/ .

SORL Auto Parts, Inc.

CONTACT: SORL Auto Parts, Inc., Ben Chen, Director of Investor Relations,
+86-577-6581-7721, ben@sorl.com.cn or ICR, Inc., Brian M. Prenoveau, CFA,
+1-203-682-8200, brian.prenoveau@icrinc.com and Yuening Jiang,
+86-10-6599-7965, yuening.jiang@icrinc.com, both for SORL Auto Parts, Inc.

Web site: http://www.sorl.cn/

FirstEnergy Seeking Additional Renewable Energy Credits for Ohio Utilities

AKRON, Ohio, Sept. 2 /PRNewswire-FirstCall/ -- FirstEnergy Corp. announced that a second Request for Proposal (RFP) will be conducted to secure renewable energy credits (RECs) for customers of its Ohio utilities -- Ohio Edison, Cleveland Electric Illuminating Company and Toledo Edison.

The RECs, combined with those acquired in an initial RFP conducted earlier this year, will be used to help meet the renewable energy requirements established under Ohio's new energy law for 2009, 2010, and 2011.

The second RFP will focus on solar and other renewable energy RECs generated in Ohio. Bidding information will be available at http://www.firstenergyrenewable.com/2009OhioRFP2. Questions will be answered directly through the Web site. To participate, bidders must submit bids and credit information by October 14, 2009. The RFP process is managed by Navigant Consulting, a global consulting firm with expertise in energy markets and procurement. The RFP Manager is Leah Bissonette, director, Navigant Consulting. She can be reached at (516) 876-4036, or email at rfp@navigantconsulting.com.

No energy or capacity will be purchased under this RFP. The number of individual bidders is not limited. Participants must prove their RECs are certified or in the process of becoming certified by the Public Utilities Commission of Ohio. Information on the PUCO's certification process can be found at http://www.puco.ohio.gov/PUCO/Forms/Form.cfm?id=9464.

FirstEnergy is a diversified energy company headquartered in Akron, Ohio. Its subsidiaries and affiliates are involved in the generation, transmission and distribution of electricity, as well as energy management and other energy-related services. Its seven electric utility operating companies comprise the nation's fifth largest investor-owned electric system, based on 4.5 million customers served, within a 36,100-square-mile area of Ohio, Pennsylvania and New Jersey; and its generation subsidiaries control more than 14,000 megawatts of capacity.

Forward-Looking Statements: This news release includes forward-looking statements based on information currently available to management. Such statements are subject to certain risks and uncertainties. These statements include declarations regarding management's intents, beliefs and current expectations. These statements typically contain, but are not limited to, the terms "anticipate," "potential," "expect," "believe," "estimate" and similar words. Forward-looking statements involve estimates, assumptions, known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Actual results may differ materially due to the speed and nature of increased competition in the electric utility industry and legislative and regulatory changes affecting how generation rates will be determined following the expiration of existing rate plans in Pennsylvania, the impact of the Public Utilities Commission of Ohio's regulatory process on the Ohio Companies associated with the distribution rate case, economic or weather conditions affecting future sales and margins, changes in markets for energy services, changing energy and commodity market prices and availability, replacement power costs being higher than anticipated or inadequately hedged, the continued ability of FirstEnergy's regulated utilities to collect transition and other charges or to recover increased transmission costs, maintenance costs being higher than anticipated, other legislative and regulatory changes, revised environmental requirements, including possible greenhouse gas emission regulations, the potential impacts of the U.S. Court of Appeals' July 11, 2008 decision requiring revisions to the Clean Air Interstate Rules and the scope of any laws, rules or regulations that may ultimately take their place, the uncertainty of the timing and amounts of the capital expenditures needed to, among other things, implement the Air Quality Compliance Plan (including that such amounts could be higher than anticipated or that certain generating units may need to be shut down) or levels of emission reductions related to the Consent Decree resolving the New Source Review litigation or other similar potential regulatory initiatives or actions, adverse regulatory or legal decisions and outcomes (including, but not limited to, the revocation of necessary licenses or operating permits and oversight) by the Nuclear Regulatory Commission, Metropolitan Edison Company's and Pennsylvania Electric Company's transmission service charge filings with the Pennsylvania Public Utility Commission, the continuing availability of generating units and their ability to operate at or near full capacity, the ability to comply with applicable state and federal reliability standards, the ability to accomplish or realize anticipated benefits from strategic goals (including employee workforce initiatives), the ability to improve electric commodity margins and to experience growth in the distribution business, the changing market conditions that could affect the value of assets held in FirstEnergy's nuclear decommissioning trusts, pension trusts and other trust funds, and cause it to make additional contributions sooner, or in an amount that is larger than currently anticipated, the ability to access the public securities and other capital and credit markets in accordance with FirstEnergy's financing plan and the cost of such capital, changes in general economic conditions affecting the company, the state of the capital and credit markets affecting the company, interest rates and any actions taken by credit rating agencies that could negatively affect FirstEnergy's access to financing or its costs or increase its requirements to post additional collateral to support outstanding commodity positions, letters of credit and other financial guarantees, the continuing decline of the national and regional economy and its impact on the company's major industrial and commercial customers, issues concerning the soundness of financial institutions and counterparties with which FirstEnergy does business, and the risks and other factors discussed from time to time in its Securities and Exchange Commission filings, and other similar factors. The foregoing review of factors should not be construed as exhaustive. New factors emerge from time to time, and it is not possible for management to predict all such factors, nor assess the impact of any such factor on FirstEnergy's business or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statements. FirstEnergy expressly disclaims any current intention to update any forward-looking statements contained herein as a result of new information, future events, or otherwise.

FirstEnergy Corp.

CONTACT: News Media Contact: Mark Durbin, +1-330-761-4365, Investor
Contact:: Ron Seeholzer, +1-330-384-5415

Web Site: http://www.firstenergycorp.com/

Synthesis Energy Systems to Report Year End 2009 Financial Results on Tuesday, September 15, 2009Conference Call and Webcast Scheduled for 8:00 a.m. ET on September 15, 2009

HOUSTON, Sept. 2 /PRNewswire-FirstCall/ -- Synthesis Energy Systems, Inc. ("SES" or the "Company") , a global industrial gasification company, today announced that it will release financial results for the year ended June 30, 2009 before the market opens on Tuesday, September 15, 2009. Senior management will hold a conference call to review the Company's financial results for this period and provide an update on corporate developments at 8:00 a.m. Eastern Time on September 15, 2009.

To access the live webcast, please log onto the Company's website at http://www.synthesisenergy.com/. Alternatively, callers may participate in the conference call by dialing (612) 332-0107. An archived version of the webcast will be available on the website through October, 15, 2009. A telephone replay of the conference call will be available approximately two hours after the completion of the call through Monday, September 21, 2009. Callers can access the replay by dialing (320) 365-3844; the PIN access number is 114485.

About Synthesis Energy Systems, Inc.

SES is an energy and technology company that builds, owns and operates coal gasification plants that utilize its proprietary U-GAS fluidized bed gasification technology to convert low rank coal, coal wastes and biomass into higher value energy and chemical products, such as transportation fuel, substitute natural gas, fuel gas, methanol and ammonia. The U-GAS technology, which SES licenses from the Gas Technology Institute, gasifies coal without many of the harmful emissions normally associated with coal combustion plants. The primary advantages of U-GAS relative to other gasification technologies are (a) greater fuel flexibility provided by our ability to use all ranks of coal (including low rank, high ash and high moisture coals, which are significantly cheaper than higher grade coals), many coal waste products and biomass feed stocks; and (b) our ability to operate efficiently on a smaller scale, which enables us to construct plants more quickly, at a lower capital cost, and, in many cases, in closer proximity to coal sources. SES currently has offices in Houston, Texas and Shanghai, China. For more information on SES, visit or call (713) 579-0600.

Synthesis Energy Systems, Inc.

CONTACT: Ann Tanabe, Vice President of Investor Relations of Synthesis
Energy Systems, Inc., +1-713-579-0600, Ann.tanabe@synthesisenergy.com

Web Site: http://www.synthesisenergy.com/

LSI to Present at Deutsche Bank 2009 Technology Conference

MILPITAS, Calif., Sept. 2 /PRNewswire-FirstCall/ -- LSI Corporation today announced that Abhi Talwalkar, President and Chief Executive Officer, will be presenting at the Deutsche Bank 2009 Technology Conference in San Francisco, Calif., on Monday, September 14, 2009, at 2:30 p.m. Pacific Time.

The presentation will be available to the public via audio webcast at http://www.lsi.com/webcast. Following the conference, a replay of the webcast will be available on the LSI website at http://www.lsi.com/webcast.

About LSI

LSI Corporation is a leading provider of innovative silicon, systems and software technologies that enable products which seamlessly bring people, information and digital content together. The company offers a broad portfolio of capabilities and services including custom and standard product ICs, adapters, systems and software that are trusted by the world's best known brands to power leading solutions in the Storage and Networking markets. More information is available at http://www.lsi.com/.

Editor's Notes: 1. All LSI news releases (financial, acquisitions, manufacturing, products, technology, etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, http://www.lsi.com/. 2. LSI and the LSI & Design logo are trademarks or registered trademarks of LSI Corporation.

LSI Corporation

CONTACT: Media Relations, Mitch Seigle, +1-408-954-3225,
mitch.seigle@lsi.com, or Investor Relations, Sujal Shah, +1-610-712-5471,
sujal.shah@lsi.com, both of LSI Corporation

Web Site: http://www.lsi.com/

Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences

EMERYVILLE, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. today announced that it will present at two healthcare conferences in September.

Robert W. Baird & Co. 2009 Health Care Conference

Onyx will present at the Robert W. Baird & Co. 2009 Health Care Conference in New York, New York, on September 9, 2009 at 9:30 a.m. Eastern Time.

Thomas Weisel Partners Healthcare Conference

Subsequently, Onyx will present at the Thomas Weisel Partners Healthcare Conference in Boston, Massachusetts, on September 10, 2009 at 12:55 p.m. Eastern Time.

Interested parties may access a live webcast of both presentations on our website at:

http://www.onyx-pharm.com/view.cfm/32/Event-Calendar

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentations will be available one hour following the conclusion of the presentations through October 9, 2009.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar , a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. For more information about Onyx, visit the company's website at http://www.onyxpharm.com/.

Nexavar (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation.

Onyx Pharmaceuticals, Inc.

CONTACT: Alex Santos of Onyx Pharmaceuticals, Inc., +1-510-597-6504

Web Site: http://www.onyx-pharm.com/

ACPT Executes Agreement to Sell Puerto Rico Apartments

ST. CHARLES, Md., Sept. 2 /PRNewswire-FirstCall/ -- American Community Properties Trust (ACPT) (the "Company") (NYSE Amex: APO) announced today that it has completed the sale of its wholly owned subsidiary, Interstate General Properties, LP (IGP) to Partners Business Equities, LLC (PBE) and its associates for $14.3 million. Prior to the sale, IGP was restructured to include only the Company's general and limited partnership interests in nine partnerships which own twelve properties with 2,653 subsidized apartments in Puerto Rico, as well as the Section 8 affordable housing management contracts. ACPT will maintain its presence in Puerto Rico through its residential and commercial land holdings. PBE was formed by members of the IGP management team.

Steve Griessel, Chief Executive Officer, said the Company will use the net proceeds from the sale to strengthen the Company's balance sheet. "This sale will help the Company structure itself in a manner so that it can independently operate our two lines of business, operating real estate and land development," said Mr. Griessel. "This sale was also a critical component of our strategic imperative to generate free cash flow for the Company and simplify and reduce operating costs."

Mathew M. Martin, Chief Financial Officer, said the sale of IGP will reduce the Company's reported consolidated debt by $81 million. In addition, PBE assumed the remaining term of IGP's office lease in the Company's Escorial Office Building consisting of 10,476 square feet and 102 employees, which represents 89.5 percent of ACPT's Company's Puerto Rico employees. Going forward, the Company expects to save in excess of $2 million in general and administrative expenses annually as a result of the sale. The Company generated net cash of $9.74 million from the sale, which is net of fees and withholding taxes.

"We believe this sale, in combination with other measures taken by the Company, will provide the financial resources and flexibility to fund continuing operations, and leave us well-positioned for potential future growth opportunities," said Mr. Martin.

"This sale represents a significant milestone in the Company's history because the Puerto Rico apartments have been an integral aspect of our business for three decades and as such it was a tough but necessary decision said Mr. Griessel. "Moving forward, the Company will continue to aggressively pursue further strategic objectives that we believe will enable our Company to prosper and grow."

ACPT is a diversified real estate organization with operations in Maryland and Puerto Rico, is currently listed on the NYSE Amex Exchange under the symbol "APO."

For more information about ACPT, visit http://www.acptrust.com/. For more information about the planned community of St. Charles, visit http://www.stcharlesmd.com/.

American Community Properties Trust

CONTACT: Craig Renner, +1-301-843-8600

Web Site: http://www.acptrust.com/

NCI Building Systems to Release Fiscal Third Quarter Results on Wednesday, September 9, 2009; Will Not Hold Conference Call Due to Impending Convertible Note Exchange Offer

HOUSTON, Sept. 2 /PRNewswire-FirstCall/ -- NCI Building Systems, Inc. announced that it will release its results for the fiscal third quarter ended August 2, 2009 after the close of the market on Wednesday, September 9, 2009. In light of the Company's proposed exchange offer to acquire its outstanding convertible notes in exchange for cash and Company common stock, which is expected to be launched on or prior to September 9, 2009, the Company will not hold its previously announced conference call following the release of its results. The Company will provide an expanded version of its earnings release to cover the subject matter usually contained in management's prepared conference call remarks.

NCI intends to resume its post-results conference call program with the release of its fiscal fourth quarter results in mid December.

NCI Building Systems, Inc. is one of North America's largest integrated manufacturers of metal products for the nonresidential building industry. NCI is comprised of a family of companies operating manufacturing facilities across the United States and Mexico, with additional sales and distribution offices throughout the United States and Canada.

CONTACT: Lynn Morgen or Betsy Brod, both of MBS Value Partners, +1-212-750-5800.

Additional Information and Where To Find It/Additional Disclosure:

In connection with the proposed exchange offer by the Company to acquire all of the Company's outstanding 2.125% Convertible Senior Subordinated Notes due 2024 (the "convertible notes"), issued under that indenture, dated as of November 16, 2004, between the Company and The Bank of New York, as trustee, in exchange for cash and shares of Company common stock, the Company expects to file with the U.S. Securities and Exchange Commission (the "SEC") a registration statement on Form S-4, a tender offer statement on Schedule TO and related documents and materials. Investors and security holders are strongly urged to carefully review the registration statement, the tender offer statement and the other related documents and materials filed with the SEC, as well as any amendments and supplements thereto, when they become available because they will contain important information about the Company, the proposed exchange offer and related transactions.

The final offer document and prospectus relating to the proposed exchange offer will be mailed to the holders of the convertible notes. Investors and security holders may obtain a free copy of the registration statement, tender offer statement and the final offer document and prospectus (when available), as well as other documents filed by the Company with the SEC, at the SEC's web site, http://www.sec.gov/. Free copies of NCI's filings with the SEC may also be obtained from the Company's Investor Relations Department at P.O. Box 692055, Houston, Texas 77269-2055 or by phone at (281) 897-7788.

This communication shall not constitute an offer to exchange or sell, or the solicitation of an offer to exchange or buy, securities, nor shall there be any exchange or sale of such securities in any jurisdiction in which such offer, exchange, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Such an offer may be made solely by a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended. Accordingly, the proposed offer for the Company's convertible notes described in this communication has not commenced. At the time that the contemplated offer is commenced, the Company will file a statement on Schedule TO and registration statement on Form S-4 with the SEC. The distribution of this communication may, in some countries, be restricted by law or regulation. Accordingly, persons who come into possession of this document should inform themselves of and observe these restrictions.

Forward Looking Statements:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 27A of the Securities Act. These statements and other statements identified by words such as "guidance," "potential," "expect," "should" and similar expressions are forward looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that may cause NCI's actual performance to differ materially from that projected in such statements. Among the factors that could cause actual results to differ materially are: the occurrence of any event, change or other circumstance that could give rise to the termination of the investment agreement with Clayton, Dubilier & Rice Fund VIII, L.P.; the inability to complete the transactions contemplated by the investment agreement due to failure to satisfy conditions to such transactions (including with respect to the refinancing of the senior credit facility and the convertible notes); the failure of the transactions contemplated by the investment agreement to close for any reason; the outcome of any legal proceedings that may be instituted against the Company and others following the announcement of the investment agreement, the transactions contemplated thereby, including the convertible notes exchange offer; risks that the proposed transactions disrupt current plans and operations and the potential difficulties in employee retention; industry cyclicality and seasonality and adverse weather conditions; ability to service the Company's debt; fluctuations in customer demand and other patterns; raw material pricing and supply; competitive activity and pricing pressure; general economic conditions affecting the construction industry; the current financial crisis and U.S. recession; changes in laws or regulations; the volatility of the Company's stock price; the potential dilution associated with the convertible notes exchange offer; the Company's ability to comply with the financial tests and covenants in its existing and future debt obligations; the significant demands on the Company's liquidity while current economic and credit conditions are severely affecting its operations; and the uncertainty surrounding the transactions described herein, including the Company's ability to retain employees, customers and vendors. Item 1A "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended November 2, 2008, identifies other important factors, though not necessarily all such factors, that could cause future outcomes to differ materially from those set forth in the forward-looking statements. NCI expressly disclaims any obligation to release publicly any updates or revisions to these forward-looking statements to reflect any changes in its expectations.

NCI Building Systems, Inc.

CONTACT: Lynn Morgen or Betsy Brod, both of MBS Value Partners,
+1-212-750-5800, for NCI Building Systems, Inc.

Bank of America Announces Acceptance of California State-Issued Registered Warrants, and Will Pay Interest, for Customers and Clients

SAN FRANCISCO, Sept. 2 /PRNewswire/ -- Bank of America today issued the following statement regarding its decision to accept California state-issued registered warrants:

(Logo: http://www.newscom.com/cgi-bin/prnh/20050720/CLW086LOGO-b )

"Bank of America is pleased the State of California will begin redeeming registered warrants earlier than anticipated. As a service to eligible customers and the state, beginning September 9, Bank of America will accept registered warrants for deposit, and will credit the interest owed by the state on these items to customers' accounts within approximately 30 days. Bank of America will offer this option through October 9, and will also advise customers how they can redeem the items directly with the State Treasurer's Office."

Bank of America

Bank of America is one of the world's largest financial institutions, serving individual consumers, small- and middle-market businesses and large corporations with a full range of banking, investing, asset management and other financial and risk management products and services. The company provides unmatched convenience in the United States, serving approximately 53 million consumer and small business relationships with more than 6,100 retail banking offices, more than 18,500 ATMs and award-winning online banking with 29 million active users. Bank of America is among the world's leading wealth management companies and is a global leader in corporate and investment banking and trading across a broad range of asset classes serving corporations, governments, institutions and individuals around the world. Bank of America offers industry-leading support to more than 4 million small business owners through a suite of innovative, easy-to-use online products and services. The company serves clients in more than 150 countries. Bank of America Corporation stock is a component of the Dow Jones Industrial Average and is listed on the New York Stock Exchange.

http://www.bankofamerica.com/

Photo: http://www.newscom.com/cgi-bin/prnh/20050720/CLW086LOGO-b Bank of America

CONTACT: Colleen Haggerty, Bank of America, +1-213-621-7414,
colleen.haggerty@bankofamerica.com

Web Site: http://www.bankofamerica.com/

Oxford Industries Reports Second Quarter Results-- Reports Sales of $193 million and Earnings of $0.03 per Share; Adjusted Earnings of $0.30 per Share--

ATLANTA, Sept. 2 /PRNewswire-FirstCall/ -- Oxford Industries, Inc. today announced financial results for its fiscal 2009 second quarter, which ended August 1, 2009. Consolidated net sales were $192.9 million in the second quarter of fiscal 2009 compared to $230.5 million in the second quarter of fiscal 2008. Diluted net earnings per share were $0.03 compared to $0.09 in the second quarter of fiscal 2008.

During the quarter, the Company undertook restructuring initiatives within its Ben Sherman operating group including the exit from, and subsequent licensing of, its footwear operations, as well as other cost-saving initiatives. As a result, the Company noted that its earnings included restructuring charges of $0.06 per diluted share in the second quarter of fiscal 2009. Results also included a $0.13 per diluted share charge due to LIFO accounting and an $0.08 per diluted share charge for the write off of unamortized deferred financing costs associated with the retirement of its senior unsecured notes in June 2009.

Excluding the impact of these charges, adjusted diluted net earnings per share in the second quarter of fiscal 2009 were $0.30 compared to adjusted diluted net earnings per share of $0.37 in the second quarter of fiscal 2008. For reference, a table reconciling GAAP net earnings per share to adjusted net earnings per share for the second quarter and first half of fiscal 2009 and fiscal 2008 is included at the end of this release.

J. Hicks Lanier, Chairman and Chief Executive Officer of Oxford Industries, Inc., commented, "Our people have risen to the occasion in these challenging times. This quarter's operating results, which exceeded our original plan, reflect solid performances by our Tommy Bahama, Lanier Clothes and Oxford Apparel businesses. Our results have been enhanced through carefully managed inventories and comprehensive cost reduction efforts. We are confident that we have the right team and the right strategies to deliver value to our customers and shareholders."

Operating Results

Tommy Bahama reported net sales of $94.4 million for the second quarter of fiscal 2009 compared to $112.0 million in the second quarter of fiscal 2008. The sales decrease was due to the difficult economic environment partially offset by sales in stores opened after the beginning of the second quarter of fiscal 2008 and increased e-commerce sales. Tommy Bahama's operating income for the second quarter of fiscal 2009 was $13.4 million compared to $18.1 million in the second quarter of fiscal 2008. The decrease in operating income was primarily due to the sales reduction and decreased royalty income partially offset by reductions in SG&A and higher gross margins. At the end of the second quarter, Tommy Bahama operated 84 retail stores compared to 78 on August 2, 2008.

Ben Sherman reported net sales of $23.6 million for the second quarter of fiscal 2009 compared to $32.5 million in the second quarter of fiscal 2008. The reduction in sales was primarily due to the 18% reduction in the average exchange rate of the British pound versus the United States dollar as well as reduced wholesale shipments due to the challenging market conditions. Ben Sherman reported an operating loss of $6.3 million in the second quarter of fiscal 2009 compared to an operating loss of $2.0 million in the second quarter of fiscal 2008. The increased loss was primarily due to the lower sales, the unfavorable impact on cost of goods sold related to inventory purchases denominated in U.S. dollars but sold in other currencies, $1.4 million of restructuring charges and lower royalty income. These items were partially offset by reductions in SG&A.

Net sales for Lanier Clothes were $25.2 million in the second quarter of fiscal 2009 compared to $28.2 million reported in the second quarter of fiscal 2008. Lanier Clothes reported a material improvement in operating results due to improved gross margins and reductions in SG&A. Operating income in the second quarter of fiscal 2009 was $2.7 million compared to an $11.4 million operating loss in the second quarter of fiscal 2008. The second quarter of fiscal 2008 included $9.5 million of restructuring charges and certain other unusual items.

Oxford Apparel reported net sales of $49.5 million for the second quarter of fiscal 2009 compared to $58.0 million in the second quarter of fiscal 2008. Despite the decrease in net sales, operating income for Oxford Apparel improved to $4.1 million for the second quarter of fiscal 2009 compared to $3.7 million in the second quarter of fiscal 2008. The impact of decreased sales was offset by reductions in SG&A related to reduced employment costs and variable operating expenses. The second quarter of fiscal 2008 included a net charge of $0.3 million related to impairment and other charges partially offset by gains from the resolution of a contingent liability and sale of a trademark.

The Corporate and Other operating loss increased to $6.4 million for the second quarter of fiscal 2009 from $0.5 million in the second quarter of fiscal 2008. The increased loss was due primarily to a LIFO accounting charge of $2.9 million in the second quarter of fiscal 2009 compared to a LIFO accounting credit of $3.3 million in the second quarter of fiscal 2008.

Consolidated gross margins for the second quarter of fiscal 2009 were 40.7% compared to 41.9% in the second quarter of fiscal 2008. The decrease in gross margin was primarily due to the impact of LIFO accounting adjustments and the negative impact on Ben Sherman's gross margins related to inventory purchases denominated in United States dollars but sold in other currencies. The second quarter of fiscal 2008 included $5.3 million of restructuring charges, which impacted cost of goods sold in Lanier Clothes and Oxford Apparel.

SG&A for the second quarter of fiscal 2009 decreased to $73.6 million, or 38.2% of net sales, compared to $89.0 million, or 38.6% of net sales, in the second quarter of fiscal 2008. The decrease in SG&A was primarily due to significant reductions in the Company's overhead cost structure, cost reductions associated with the exit from certain businesses, the impact of the decline in the British pound versus the United States dollar and reductions in advertising expense. The second quarter of fiscal 2009 and the second quarter of fiscal 2008 included net charges of $1.4 million and $1.6 million respectively, related to restructuring charges and other unusual items.

Royalties and other operating income for the second quarter of fiscal 2009 were $2.9 million compared to $4.4 million in the second quarter of fiscal 2008. The decrease was primarily due to the Company's termination of the license agreement for footwear in Tommy Bahama, the decline in the British pound versus the United States dollar, which impacted Ben Sherman royalty income, and the generally difficult economic conditions. The Company noted that the second quarter of fiscal 2008 included a gain on the sale of a trademark by Oxford Apparel.

Interest expense for the second quarter of fiscal 2009 was $6.2 million, which includes the write off of $1.8 million of unamortized deferred financing costs, compared to $6.0 million in the second quarter of fiscal 2008. The Company expects to incur approximately $5.3 million of interest expense in each of the third and fourth quarters of fiscal 2009.

For the first half of fiscal 2009 consolidated net sales decreased to $409.6 million from $503.5 million in the first half of fiscal 2008. Excluding the impact of restructuring charges and other unusual items, adjusted diluted net earnings per share in the first half of fiscal 2009 decreased to $0.79 from adjusted diluted net earnings per share of $0.99 in the first half of fiscal 2008. Including the restructuring charges and other unusual items, in the first half of fiscal 2009, earnings per diluted share were $0.45 compared to $0.69 in the first half of fiscal 2008.

Balance Sheet and Liquidity

Total inventories at the close of the second quarter of fiscal 2009 were $97.4 million, down 25% from the close of the second quarter of fiscal 2008. Inventory levels at Ben Sherman, Lanier Clothes and Oxford Apparel have each decreased as the Company focused on mitigating inventory markdown risk and promotional pressure, as well as exiting certain lines of business. Inventory levels increased slightly year over year at Tommy Bahama to support additional retail stores. Receivables totaled $78.5 million at quarter end, down 19% from the end of last year's second quarter. The decrease was attributable to lower wholesale sales.

During the second quarter of fiscal 2009, the Company completed a private offering of $150 million aggregate principal amount of 11-3/8% Senior Secured Notes due 2015. The net proceeds from the offering, together with borrowings under the Company's U.S. revolving credit facility, were used to repurchase, repay and/or discharge all $166.8 million aggregate principal amount of the Company's then outstanding 8-7/8% Senior Unsecured Notes due 2011.

As a result of strong cash flow from operations, total debt was reduced from $221.6 million at August 2, 2008 to $180.8 million at August 1, 2009. As of August 1, 2009, the Company had approximately $97.3 million in unused availability under its U.S. revolving credit facility and $3.7 million in unused availability under its U.K. revolving credit facility.

The Company's capital expenditures for fiscal 2009, including $5.8 million incurred during the first half of fiscal 2009, are expected to be approximately $10 million. These expenditures will consist primarily of additional Tommy Bahama and Ben Sherman retail stores and the costs associated with the implementation of a new integrated financial system.

Fiscal 2009 Guidance

For the full fiscal year 2009, the Company expects net sales in the range of $765 million to $780 million, with a greater year over year sales decrease in the third quarter than the fourth quarter. Adjusted diluted net earnings per share for fiscal 2009 are expected to be between $0.90 and $1.05.

Dividend

The Company also announced that its Board of Directors has approved a cash dividend of $0.09 per share payable on October 30, 2009 to shareholders of record as of the close of business on October 15, 2009. The Company has paid dividends every quarter since it became publicly owned in 1960.

Conference Call

The Company will hold a conference call with senior management to discuss its financial results at 4:30 p.m. EDT today. A live web cast of the conference call will be available on the Company's website at http://www.oxfordinc.com/. Please visit the website at least 15 minutes before the call to register for the teleconference web cast and download any necessary software. A replay of the call will be available through September 16, 2009. To access the telephone replay, participants should dial (719) 457-0820. The access code for the replay is 7791234. A replay of the web cast will also be available following the teleconference on the Company's website at http://www.oxfordinc.com/.

About Oxford:

Oxford Industries, Inc. is an international apparel design, sourcing and marketing company featuring a diverse portfolio of owned and licensed brands and a collection of private label apparel businesses. Oxford's brands include Tommy Bahama , Ben Sherman , Arnold Brant , Ely & Walker , and Oxford Golf . The Company also holds exclusive licenses to produce and sell certain product categories under the Kenneth Cole , Geoffrey Beene and Dockers labels. Oxford's wholesale customers are found in every major channel of distribution, including national chains, specialty catalogs, mass merchants, department stores, specialty stores and Internet retailers. The Company operates retail stores, restaurants and Internet websites for some of its brands. The Company also has license arrangements with select third parties to produce and sell certain product categories under its Tommy Bahama and/or Ben Sherman brands. Oxford's stock has traded on the New York Stock Exchange since 1964 under the symbol OXM. For more information, please visit Oxford's website at http://www.oxfordinc.com/.

CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING STATEMENTS

This press release may include statements that are forward-looking statements within the meaning of the federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions identify forward-looking statements, which generally are not historical in nature. We intend for all forward-looking statements contained herein or on our website, and all subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf, to be covered by the safe harbor provisions for forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Important assumptions relating to these forward-looking statements include, among others, assumptions regarding the impact on consumer demand and spending of recent economic conditions, demand for our products, timing of shipments requested by our wholesale customers, expected pricing levels, competitive conditions, the timing and cost of planned capital expenditures, costs of products and raw materials we purchase, access to capital and/or credit markets, particularly in light of recent conditions in those markets, expected outcomes of pending or potential litigation and regulatory actions and disciplined execution by key management. Forward-looking statements reflect our current expectations, based on currently available information, and are not guarantees of performance. Although we believe that the expectations reflected in such forward-looking statements are reasonable, these expectations could prove inaccurate as such statements involve risks and uncertainties, many of which are beyond our ability to control or predict. Should one or more of these risks or uncertainties, or other risks or uncertainties not currently known to us or that we currently deem to be immaterial, materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. Important factors relating to these risks and uncertainties include, but are not limited to, those described in Part I, Item 1A. Risk Factors contained in our Annual Report on Form 10-K for fiscal 2008 and those described from time to time in our future reports filed with the SEC.

We caution that one should not place undue reliance on forward-looking statements, which speak only as of the date on which they are made. We disclaim any intention, obligation or duty to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

OXFORD INDUSTRIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (in thousands, except per share amounts) Second Second First First Quarter Quarter Half Half Fiscal Fiscal Fiscal Fiscal 2009 2008 2009 2008 ------------------------------------- Net sales $192,887 $230,520 $409,618 $503,462 Cost of goods sold 114,344 133,849 241,304 290,482 ------------------------------------- Gross profit 78,543 96,671 168,314 212,980 SG&A 73,637 88,972 152,320 188,606 Amortization of intangible assets 315 4,058 623 4,846 ------------------------------------ 73,952 93,030 152,943 193,452 Royalties and other operating income 2,916 4,351 5,385 8,539 ------------------------------------ Operating income 7,507 7,992 20,756 28,067 Interest expense, net 6,245 5,985 10,810 12,317 ------------------------------------ Earnings before income taxes 1,262 2,007 9,946 15,750 Income taxes 729 534 2,901 4,760 ------------------------------------ Net earnings $533 $1,473 $7,045 $10,990 ==================================== Net earnings per common share: Basic $0.03 $0.09 $0.45 $0.70 Diluted $0.03 $0.09 $0.45 $0.69 Weighted average common shares outstanding: Basic 15,565 15,578 15,543 15,778 Dilution 109 75 68 90 ------------------------------------ Diluted 15,674 15,653 15,611 15,868 ==================================== Dividends declared per common share $0.09 $0.18 $0.18 $0.36 OXFORD INDUSTRIES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (in thousands, except par amounts) August 1, August 2, 2009 2008 ------------------- ASSETS Current Assets: Cash and cash equivalents $5,461 $5,243 Receivables, net 78,467 96,463 Inventories, net 97,378 129,904 Prepaid expenses 19,395 22,026 ------------------- Total current assets 200,701 253,636 Property, plant and equipment, net 86,365 94,471 Goodwill, net - 257,699 Intangible assets, net 138,880 225,612 Other non-current assets, net 22,932 27,866 ------------------- Total Assets $448,878 $859,284 =================== LIABILITIES AND SHAREHOLDERS' EQUITY Current Liabilities: Trade accounts payable and other accrued expenses $75,827 $97,638 Accrued compensation 11,132 14,802 Short-term debt and current maturities of long-term debt 20,417 3,027 ------------------- Total current liabilities 107,376 115,467 Long-term debt, less current maturities 160,357 218,604 Other non-current liabilities 46,804 52,724 Non-current deferred income taxes 30,013 59,046 Commitments and contingencies Shareholders' Equity: Common stock, $1.00 par value; 60,000 authorized and 16,520 issued and outstanding at August 1, 2009; and 15,858 issued and outstanding at August 2, 2008 16,520 15,858 Additional paid-in capital 89,253 86,300 Retained earnings 20,561 298,947 Accumulated other comprehensive income (loss) (22,006) 12,338 ------------------- Total shareholders' equity 104,328 413,443 ------------------- Total Liabilities and Shareholders' Equity $448,878 $859,284 =================== OXFORD INDUSTRIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (in thousands) First First Half Half Fiscal Fiscal 2009 2008 ------------------ Cash Flows From Operating Activities: Net earnings $7,045 $10,990 Adjustments to reconcile net earnings to net cash provided by operating activities: Depreciation 9,259 9,983 Amortization of intangible assets 623 4,846 Amortization of deferred financing costs and bond discount 2,392 1,307 Stock compensation expense 1,637 1,667 Loss on sale of property, plant and equipment 42 294 Equity method investment income (590) (329) Deferred income taxes (2,650) (1,596) Changes in working capital: Receivables 2,574 8,983 Inventories 34,389 28,907 Prepaid expenses (2,255) (3,555) Current liabilities (17,601) (3,246) Other non-current assets 747 2,070 Other non-current liabilities (506) 1,823 ------------------ Net cash provided by operating activities 35,106 62,144 Cash Flows From Investing Activities: Investments in unconsolidated entities - (446) Purchases of property, plant and equipment (5,840) (12,280) Proceeds from sale of property, plant and equipment - 4 ------------------ Net cash used in investing activities (5,840) (12,722) Cash Flows From Financing Activities: Repayment of revolving credit arrangements (138,135) (161,870) Proceeds from revolving credit arrangements 138,859 111,115 Repurchase of 8 7/8% Senior Unsecured Notes (166,805) - Proceeds from the issuance of 11 3/8% Senior Secured Notes 146,029 - Proceeds from issuance of common stock 193 53 Payments of debt issuance costs (4,878) - Dividends on common stock (2,919) (8,701) ------------------ Net cash used in financing activities (27,656) (59,403) ------------------ Net change in cash and cash equivalents 1,610 (9,981) Effect of foreign currency translation on cash and cash equivalents 561 312 Cash and cash equivalents at the beginning of year 3,290 14,912 ------------------ Cash and cash equivalents at the end of period $5,461 $5,243 ================== OXFORD INDUSTRIES, INC. OPERATING GROUP INFORMATION (UNAUDITED) (in thousands) Second Second First First Quarter Quarter Half Half Fiscal Fiscal Fiscal Fiscal 2009 2008 2009 2008 -------------------------------------- Net Sales Tommy Bahama $94,439 $112,007 $192,859 $241,265 Ben Sherman 23,627 32,495 47,846 69,082 Lanier Clothes 25,204 28,184 56,711 66,871 Oxford Apparel 49,464 58,024 112,668 126,708 Corporate and Other 153 (190) (466) (464) -------------------------------------- Total Net Sales $192,887 $230,520 $409,618 $503,462 ====================================== Operating Income (loss) Tommy Bahama $13,379 $18,143 $25,629 $37,626 Ben Sherman (6,308) (2,002) (8,284) (1,747) Lanier Clothes 2,701 (11,355) 5,438 (11,376) Oxford Apparel 4,129 3,738 9,322 9,063 Corporate and Other (6,394) (532) (11,349) (5,499) -------------------------------------- Total Operating Income (loss) $7,507 $7,992 $20,756 $28,067 Interest Expense, net 6,245 5,985 10,810 12,317 -------------------------------------- Earnings Before Income Taxes $1,262 $2,007 $9,946 $15,750 ======================================

RECONCILIATION OF GAAP NET EARNINGS (LOSS) PER DILUTED SHARE TO ADJUSTED NET EARNINGS (LOSS) PER DILUTED SHARE

Set forth below is our reconciliation of net earnings (loss) per diluted share, calculated in accordance with generally accepted accounting principles, or GAAP, to adjusted net earnings (loss) per diluted share, for the second quarter, first half and full year for fiscal 2009 and fiscal 2008. Adjusted net earnings (loss) per diluted share, excludes the impact of (i) certain restructuring charges, (ii) other unusual items, (iii) the write off of unamortized financing costs associated with changes in our debt structure, (iv) certain goodwill, intangible asset and investment in joint venture impairment charges, (v) certain property, plant and equipment impairment charges, (vi) LIFO accounting adjustments, (vii) the gain on the repurchase of $33.2 million face value of our senior unsecured notes and (viii) certain adjustments to tax expense primarily resulting from changes in contingency reserves. We believe that investors often look at ongoing operations as a measure of assessing performance and as a basis for comparing past results against future results. Therefore, we believe that presenting our results excluding these items provides useful information to investors because this allows investors to make decisions based on our ongoing operations. We use the results excluding these items to discuss our business with investment institutions, our board of directors and others. Further, we believe that presenting our results excluding these items provides useful information to investors because this allows investors to compare our results for the periods presented to other periods.

Second Second First First Full Full Quarter Quarter Half Half Year Year Fiscal Fiscal Fiscal Fiscal Fiscal Fiscal 2009 2008 2009 2008 2009 2008 Actual Actual Actual Actual Guidance Actual ------------------------------------------------------- Per Diluted Common Share: GAAP Net earnings (loss), as reported $0.03 $0.09 $0.45 $0.69 $0.56-$0.71 ($17.00) Restructuring charges (1) 0.06 0.31 0.06 0.31 0.06 0.45 Net gain from other unusual items (2) - (0.04) - (0.04) - (0.04) Unamortized financing costs written off 0.08 - 0.08 - 0.08 0.04 Impairment charges for goodwill, intangible assets and investment in joint venture - 0.14 - 0.14 - 18.66 Impairment charges for property, plant and equipment - 0.01 - 0.01 - 0.06 LIFO accounting adjustments (3) 0.13 (0.14) 0.20 (0.12) 0.20 (0.38) Gain on repurchase of Senior Unsecured Notes - - - - - (0.33) Adjustments to tax expense - - - - - (0.02) ------------------------------------------------------- Adjusted net earnings (loss) $0.30 $0.37 $0.79 $0.99 $0.90-$1.05 $1.44 ------------------------------------------------------- (1) Charges relate to inventory disposal, payments related to license termination, severance costs and charges related to vacated leased office space. (2) Unusual items include the resolution of a contingent liability and the sale of a trademark, partially offset by an increase in bad debt expense due to certain significant customer bankruptcies. (3) The first quarter of fiscal 2009 included a previously disclosed LIFO accounting charge of $1.6 million, or $0.07 per share.

Oxford Industries, Inc.

CONTACT: Anne M. Shoemaker of Oxford Industries, Inc., +1-404-653-1455,
or Fax: +1-404-653-1545, ashoemaker@oxfordinc.com

Web Site: http://www.oxfordinc.com/

Leggett & Platt Announces Webcast of September 9 Presentation

CARTHAGE, Mo., Sept. 2 /PRNewswire-FirstCall/ -- Leggett & Platt, Incorporated, a Fortune 500 diversified manufacturer of engineered products serving several major markets, announced that Susan R. McCoy, Director of Investor Relations, will speak to the investment community at the Raymond James European Investors North American Equities Conference on Wednesday, September 9, 2009 at 2:45 p.m. BST (8:45 p.m. CST) in London.

The presentation will be webcast and can be accessed from the Investor Relations section of Leggett's website at http://www.leggett.com/ for one week. Investors are encouraged to log on at least five minutes prior to the start of the presentation.

COMPANY DESCRIPTION: Leggett & Platt is a diversified manufacturer that conceives, designs and produces a broad variety of engineered components and products that can be found in most homes, offices, and automobiles. The company serves a broad suite of customers that comprise a "Who's Who" of U.S. manufacturers and retailers. The 126-year-old firm's continuing operations are composed of 19 business units, 19,000 employee-partners, and approximately 160 manufacturing facilities located in 18 countries.

Leggett & Platt is North America's leading independent manufacturer of: a) components for residential furniture and bedding; b) components for office furniture; c) drawn steel wire; d) automotive seat support and lumbar systems; e) carpet underlay; f) adjustable beds; and g) bedding industry machinery.

CONTACT: Investor Relations, (417) 358-8131 or invest@leggett.com

Susan R. McCoy, Director

Leggett & Platt

CONTACT: Susan R. McCoy, Director of Investor Relations,
+1-417-358-8131, invest@leggett.com

Web Site: http://www.leggett.com/

Continuing Focus on Defense, Security & Aerospace, Plexus Receives Far 145 Repair Station Certification

NEENAH, Wis., Sept. 2 /PRNewswire-FirstCall/ -- Plexus Corp. announced today that it has received FAR 145 Repair Station certification in Appleton, Wisconsin to support customers in the Defense, Security and Aerospace (D/S/A) industries. This certification compliments Plexus' facilities that are already compliant to AS9100 and the National Aerospace and Defense Contractors Accreditation Program (Nadcap), by allowing Plexus to repair, and return to service, aircraft components ranging from individual circuit card assemblies to line replaceable units.

Jim Anderson, Customer Management Vice President for the D/S/A Market Sector, commented, "Plexus is pleased to be a leading contract manufacturer of electronic products in the D/S/A sector. Feedback from our existing customers on this new certification has been positive. We have proactively aligned our certification activities to our customer's needs to provide seamless transitions into our engineering design centers and manufacturing sites."

Plexus has the following certifications in place to support the D/S/A industries:

-- ITAR - In place at all United States based engineering design centers and manufacturing sites -- AS9100 - In place in three sites in Wisconsin, USA, two sites in Penang, Malaysia, and one site in Kelso, Scotland -- CAS Compliance -- Nadcap - In place in two sites in Wisconsin, USA, and one site in Penang, Malaysia -- FAR 145 - In place in one site in Wisconsin, USA, and working towards compliance in one site in Penang, Malaysia, with completion slated for CY2010

"Based on customer input and technology road mapping, we have increased our efforts in this market segment to support existing and future customer requirements," stated Brian Wilson, D/S/A Market Sector Vice President. "Achieving the FAR 145 Repair Station certification is a true testament to our dedication and vision to be best in the world at serving customers in the mid- to low-volume, higher mix segment of the EMS industry."

About Plexus Corp. - The Product Realization Company

Plexus (http://www.plexus.com/) is an award-winning participant in the Electronics Manufacturing Services (EMS) industry, providing product design, supply chain and materials management, manufacturing, test, fulfillment and aftermarket solutions to branded product companies in the Wireline/Networking, Wireless Infrastructure, Medical, Industrial/Commercial and Defense/Security/Aerospace market sectors.

The Company's unique Focused Factory manufacturing model and global supply chain solutions are strategically enhanced by value-added product design and engineering services. Plexus specializes in mid- to low-volume, higher mix customer programs that require flexibility, scalability, technology and quality.

Plexus provides award-winning customer service to more than 100 branded product companies in North America, Europe and Asia Pacific.

Safe Harbor and Fair Disclosure Statement

The statements contained in this release which are guidance or which are not historical facts (such as statements in the future tense and statements including "believe," "expect," "intend," "plan," "anticipate," "goal," "target" and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include, but are not limited to: the economic performance of the electronics, technology and defense industries; the risk of customer delays, changes or cancellations in both ongoing and new programs; the poor visibility of future orders, particularly in view of current economic conditions; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers and maintain our current customer base and deliver product on a timely basis; the risks relative to new customers, including a recently announced customer in the Industrial/Commercial sector, which risks include customer delays, start-up costs, our potential inability to execute and lack of a track record of order volume and timing; the risks of concentration of work for certain customers; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; the weakness of the global economy and the continuing instability of the global financial markets and banking system, including the potential inability on our part or that of our customers or suppliers to access cash investments and credit facilities; material cost fluctuations and the adequate availability of components and related parts for production; the effect of changes in average selling prices; the effect of start-up costs of new programs and facilities, including our recent and planned expansions, such as our new facilities in Hangzhou, China and Oradea, Romania; the adequacy of restructuring and similar charges as compared to actual expenses; the degree of success and the costs of efforts to improve the financial performance of our Mexican operations; possible unexpected costs and operating disruption in transitioning programs; the potential effect of world events (such as drug-cartel related violence in Mexico, changes in oil prices, terrorism and war in the Middle East); the impact of increased competition; and other risks detailed in the Company's Securities and Exchange Commission filings (particularly in Part II, Item 1A of our quarterly report on Form 10-Q for the quarter ended July 4, 2009).

Plexus Corp.

CONTACT: Brian Wilson, Defense/Security/Aerospace Market Sector Vice
President of Plexus Corp., +1-720-890-4471, brian.wilson@plexus.com

Web Site: http://www.plexus.com/

Weis Markets Launches Month-Long Fight Hunger Food Drive

SUNBURY, Pa., Sept. 2 /PRNewswire-FirstCall/ -- Weis Markets is launching its second-annual Fight Hunger Food Drive, a month-long, chain-wide program offering its customers an opportunity to donate shelf-stable products to local food banks and emergency food providers.

The program will begin Thursday September 3 and run through the end of September. It will be held in Weis Markets stores in Pennsylvania, Maryland, New Jersey, West Virginia and in Elmira, New York.

"September is Hunger Action month and an important time for food banks as they prepare for the winter months. During these difficult economic times, there has been a significant increase in food bank demand in the areas we serve. We can help," said David J. Hepfinger, Weis Markets' President and CEO. "Our Fight Hunger Food Drive gives our associates and customers the opportunity to support eleven food banks and the hundreds of emergency food providers they serve. In addition, our company will be donating $200,000 to these food banks at the end of the campaign."

Karen Buch, Weis Markets Director of Lifestyle Initiatives, added, "We have worked with food banks to compile a list of the shelf-stable foods they need most, including: cereal, apple sauce, pasta, granola bars, canned beans, 100% fruit juice, canned fruit, grated cheese, rice, boxed mac and cheese, peanut butter, soups, canned sauces, instant potatoes, canned chicken and fish, canned vegetables and boxed skillet dinners."

New this year is the availability of $3, $5 and $10 vouchers which can be purchased at each cash register. One hundred percent of the proceeds will be given to area food banks in the form of gift card donations so they can easily fill in any gaps in their food supplies. A new, convenient pre-filled Fight Hunger Donation Bag will also be available at stores, containing pasta, sauce, fruit, vegetables, tuna, cereal and soup--all for less than seven dollars.

After customers purchase the foods they would like to donate, they can simply place the items in a specially-marked collection cart near checkout. Donors will be invited to place a "Fight Hunger" sticker on each store's front window poster.

The Fight Hunger Food Drive will benefit: The Second Harvest Food Bank of the Lehigh Valley and Northeast, PA; The Central Pennsylvania Food Bank (Harrisburg); The Central Pennsylvania Food Bank (Williamsport); The Maryland Food Bank; The Commission on Economic Opportunity/The Weinberg Northeast Regional Food Bank (Wilkes-Barre/Scranton); Greater Berks Food Bank (Reading); Food Bank of the Southern Tier (Elmira); Northwest Community Action Program NORWESCAP Food Bank (Phillipsburg, NJ); Philabundance (Philadelphia); and Mountaineer Food Bank (West Virginia).

More information on the Fight Hunger Food Donation Program and our partner food banks is available on Weis Markets' website at http://www.weismarkets.com/ or by calling Weis Markets Customer Service at (866)999-9347.

Founded in 1912, Weis Markets, Inc. is a Mid-Atlantic food retailer operating 165 stores in five states: Pennsylvania, Maryland, New Jersey, New York and West Virginia.

Weis Markets

CONTACT: Dennis Curtin, +1-570-847-3636, dcurtin@weismarkets.com

Web Site: http://www.weismarkets.com/

Kirby Corporation to Present at Jefferies 6th Annual Shipping & Offshore Services Conference

HOUSTON, Sept. 2 /PRNewswire-FirstCall/ -- Kirby Corporation ("Kirby") announced today that Joe Pyne, Kirby's President and Chief Executive Officer, will present at the Jefferies 6th Annual Shipping & Offshore Services Conference on Wednesday, September 9, 2009, at 10:15 a.m. eastern time. The Jefferies conference is being held in New York.

A live audio webcast of the presentation will be available to the public and a replay will be available after the presentation by visiting Kirby's website at http://www.kirbycorp.com/. A copy of the material prepared by Kirby for the presentation will be available at 7:00 a.m. central time on September 9, 2009 on Kirby's website. A replay of the presentation will be available through October 9, 2009 on Kirby's website.

Kirby Corporation, based in Houston, Texas, operates inland tank barges and towing vessels transporting petrochemicals, black oil products, refined petroleum products and agricultural chemicals throughout the United States' inland waterway system. Kirby also owns and operates four ocean-going barge and tug units transporting dry-bulk commodities in United States coastwise trade. Through the diesel engine services segment, Kirby provides after-market service for medium-speed and high-speed diesel engines and reduction gears used in marine, power generation and railroad applications.

This press release and the presentation may contain statements that may be considered to be forward-looking statements. These statements reflect management's reasonable judgement with respect to future events. Forward-looking statements involve risks and uncertainties. Actual results could differ materially from those anticipated as a result of various factors, including cyclical or other downturns in demand, significant pricing competition, unanticipated additions to industry capacity, changes in the Jones Act or in U.S. maritime policy and practice, fuel costs, interest rates, weather conditions, and the timing, magnitude and the number of acquisitions made by Kirby. Forward-looking statements are based on currently available information and Kirby assumes no obligation to update such statements. A list of additional risk factors can be found in Kirby's annual report on Form 10-K for the year ended December 31, 2008, filed with the Securities and Exchange Commission.

Kirby Corporation

CONTACT: Steve Holcomb, +1-713-435-1135, for Kirby Corporation

Web Site: http://www.kirbycorp.com/

Academy Award(R)-Winning Actress Hilary Swank Named 2009 Ambassador for Iams Home 4 the Holidays Pet Adoption CampaignSwank and 3,500 Adoption Organizations on a Mission to Help 1.5 Million Pets Find Homes

DAYTON, Ohio, Sept. 2 /PRNewswire/ -- After 10 years of successfully helping millions of orphaned pets find homes, Iams Home 4 the Holidays (IH4TH) today announced that two-time Academy Award-winning actress Hilary Swank will serve as the drive's 2009 ambassador. Swank will share her personal experience with adoption and rescue in an effort to help educate others about how they can make a positive impact on the lives of homeless pets. Along with founding partner Helen Woodward Animal Center and nearly 3,500 participating animal organizations from around the world, the program has set a goal to help 1.5 million pets find homes Oct. 1, 2009 through Jan. 4, 2010.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090902/LA69692)

"I'm so proud to be working with Iams Home 4 the Holidays to help raise awareness about the importance of pet adoption," said Hilary Swank, pet parent and 2009 Iams Home 4 the Holidays Ambassador. "Last year, the program's adoption goal was to get 1 million pets adopted in just three months, but this year the goal is even bigger - we're on a mission to find loving homes for 1.5 million orphaned pets between Oct. 1 and Jan. 4."

Swank has adopted many pets throughout her life, including her two dogs Karoo and Rumi. She rescued Karoo from the side of a road while filming in South Africa a few years ago and adopted Rumi last fall from a participating IH4TH shelter in Los Angeles.

"Now more than ever orphaned animals need our help and who better to give them a voice than Hilary?" said Mike Arms, founder of Iams Home 4 the Holidays and president of Helen Woodward Animal Center. "Along with Hilary and her inspiration, our 3,500 animal organizations are working to shine a big spotlight on the need to help the nearly 8 million homeless pets in our country, and are committed to helping raise awareness about the importance of pet adoption."

"Hilary's genuine passion and love for animals combined with her pet adoption experience makes her a tremendous ambassador for Iams Home 4 the Holidays," said Dan Rajczak, vice president and general manager, P&G Pet Care in North America. "We're confident that with the support of an advocate like Hilary, we'll be able to achieve or even exceed our pet adoption goal again this year and help 1.5 million pets find loving homes."

Iams Home 4 the Holidays is dedicated to helping homeless pets. The program has placed more than 3 million animals in homes since 1999, and in 2008, the adoption drive found homes for 1,202,718 pets. The 2009 program officially kicks-off on Oct. 1, but in the meantime, there are still millions of homeless animals that need help. To learn more about how to make a difference in the life of an orphaned pet, including finding participating shelters, volunteering and making a donation to support animal organizations and pets awaiting new homes, visit http://www.iamshome4theholidays.com/.

About Iams Home 4 the Holidays (IH4TH)

As one of the most successful pet adoption programs in the world, IH4TH partners thousands of animal organizations dedicated to finding forever homes for orphaned pets. Founded by Helen Woodward Animal Center and supported by Iams, IH4TH began in 1999 with just 14 participating animal shelters in San Diego County. Since it began 11 years ago, IH4TH - along with nearly 3,500 pet adoption centers - has helped more than 3,278,143 families experience the joy of pet adoption, including 1.2 million pet adoptions this past year alone. For more information, please visit http://www.iamshome4theholidays.com/ or follow us at http://www.twitter.com/IH4TH.

About Helen Woodward Animal Center

Helen Woodward Animal Center is a private, non-profit organization where "people help animals and animals help people." Founded in 1972 in Rancho Santa Fe, Calif., the Center provides services for more than 57,000 people and thousands of animals annually. Helen Woodward Animal Center is also the creator of the international Home 4 the Holidays pet adoption drive and the Animal Center Education Services program, teaching the business of saving lives to animal welfare leaders from around the world.

About P&G Pet Care

For more than 60 years, P&G Pet Care , the maker of Iams and Eukanuba, has enhanced the well-being of dogs and cats by providing world-class quality foods and pet-care products. To learn more about Eukanuba and Iams Dog & Cat Foods or general pet care and nutrition information, call the Iams Consumer Care Center at (800) 446-3075. You can also visit us on the Web at http://www.iams.com/ or http://www.eukanuba.com/.

About Procter & Gamble

Three billion times a day, P&G brands touch the lives of people around the world. The company has one of the strongest portfolios of trusted, quality, leadership brands, including Pampers , Tide , Ariel , Always , Whisper , Pantene , Mach3 , Bounty , Dawn , Gain , Pringles , Folgers , Charmin , Downy , Lenor , Iams , Crest , Oral-B , Actonel , Duracell , Olay , Head & Shoulders , Wella , Gillette , and Braun . The P&G community consists of 138,000 employees working in over 80 countries worldwide. Please visit http://www.pg.com/ for the latest news and in-depth information about P&G and its brands.

CONTACT: Heather Wilkins PainePR (949) 809-6766 hwilkins@painepr.com

Photo: http://www.newscom.com/cgi-bin/prnh/20090902/LA69692
http://photoarchive.ap.org/
AP PhotoExpress Network: PRN14
PRN Photo Desk, photodesk@prnewswire.com Iams Home 4 the Holidays

CONTACT: Heather Wilkins of PainePR, +1-949-809-6766,
hwilkins@painepr.com, for Iams Home 4 the Holidays

Web Site: http://www.iams.com/
http://www.iamshome4theholidays.com/

More Collegiate Sports Coming to Verizon's FiOS1: Princeton and Hofstra Are Latest Universities to Reach Agreements to Televise Football, Soccer and Much MoreNew Jersey and Long Island Schools Join Rutgers and Georgetown in Bringing Sports Programming to FiOS1

NEW YORK, Sept. 2 /PRNewswire/ -- Princeton and Hofstra university football, soccer and even water polo are coming to Verizon's FiOS1 channels on Long Island, and in New Jersey and the metropolitan Washington, D.C., area. The two universities are joining Rutgers and Georgetown in bringing exciting collegiate sports programming to the Verizon FiOS TV network.

"This is a great opportunity to bring Princeton and Hofstra sports to those communities where it matters most," said Michelle Webb, Verizon's general manager and chief programming officer, FiOS1 local channels. "We're kicking off the fall sports season with football and men's and women's soccer -- and that's just the beginning."

The first live football game of the 2009 season will be broadcast Saturday (Sept. 5) on FiOS1 Long Island when Hofstra takes on Stony Brook at 7 p.m. The game will be found only on Verizon's FiOS network.

"We are happy to enter into this partnership with Verizon's FiOS1," said Hofstra University Director of Athletics Jack Hayes. "Our visibility on the Verizon FiOS1 channel will give our fans another outlet to watch their favorite Pride athletic teams."

Michael Cross said Princeton University's executive associate director of athletics, said, "We are very enthusiastic about our new partnership with Verizon FiOS1 that will provide fans of Princeton Athletics with meaningful television coverage of the student athletes and coaches from many of Princeton's 38 athletic teams."

Among the Princeton events to be aired on FiOS1 over the next couple of weeks are the women's soccer team hosting Hofstra on Friday (Sept. 4) and the Princeton-Citadel football game on Sept. 19.

Other Hofstra football games to be aired on FiOS1 Long Island are James Madison at Hofstra on Oct. 3, New Hampshire at Hofstra on Oct. 24 and University of Massachusetts at Hofstra on Nov. 21.

FiOS1 New Jersey will broadcast the Rutgers women's soccer matches with Villanova on Sept. 27, Notre Dame on Oct. 9 and Syracuse on Oct. 15. The channel will also broadcast the Rutgers men's soccer match with Syracuse on Oct. 2.

In the metropolitan Washington, D.C., area, FiOS1 will broadcast the Georgetown-Yale football game on Sept. 19 and the Georgetown-Howard game on Sept. 26.

In addition to football and soccer, Verizon FiOS1 also plans to broadcast other events including basketball, wrestling and water polo. All games will be available for free on video on demand in the FiOS1 Local Zone folder.

Verizon is the only company in the U.S. to bring 100 percent fiber optics straight to the home, giving customers the ultimate home-upgrade by delivering America's top-rated broadband with download connections speeds of up to 50 megabits per second, more HD, amazing picture-and-sound quality, and interactive capabilities that cable can't match.

FiOS TV offers a broad collection of programming, with more than 500 all-digital channels, more than 115 HD channels and more than 15,000 monthly VOD titles. FiOS provides next-generation interactive services including an advanced interactive media guide; news, entertainment and social TV widgets; remote DVR management; multi-room DVR; casual games; and many others.

For the latest news, updates and information about FiOS TV, visit http://www.verizon.com/newscenter and http://www.verizon.com/athomeblog.

Verizon Communications Inc. , headquartered in New York, is a global leader in delivering broadband and other wireless and wireline communications services to mass market, business, government and wholesale customers. Verizon Wireless operates America's most reliable wireless network, serving more than 87 million customers nationwide. Verizon's Wireline operations provide converged communications, information and entertainment services over the nation's most advanced fiber-optic network. Wireline also includes Verizon Business, which delivers innovative and seamless business solutions to customers around the world. A Dow 30 company, Verizon employs a diverse workforce of more than 235,000 and last year generated consolidated operating revenues of more than $97 billion. For more information, visit http://www.verizon.com/.

VERIZON'S ONLINE NEWS CENTER: Verizon news releases, executive speeches and biographies, media contacts, high-quality video and images, and other information are available at Verizon's News Center on the World Wide Web at http://www.verizon.com/news. To receive news releases by e-mail, visit the News Center and register for customized automatic delivery of Verizon news releases.

Verizon

CONTACT: Rich Young , +1-973-649-2279, richard.j.young@verizon.com, or
John Bonomo, +1-212-321-8033, john.j.bonomo@verizon.com

Company News On-Call: http://www.prnewswire.com/comp/094251.html

page 1 page 2 page 3 page 4 page 5 page 6 page 7 page 8 page 9 page 10 page 11

News archive of November 2009
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

News Archives of September 2009
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

News Archives other dates
2009: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2008: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2007: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2006: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Datasheet begin: 0 1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Distributors inventory: 0 1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z